Undervalued US Stocks
Our undervalued US list holds 71 companies on 17 November 2026: each has rising earnings while its price sits below its own history. 42 are scored out of 100. The top three are Autodesk (ADSK), Five Below (FIVE) and DexCom (DXCM).
Every US stock list for Indian investors
Undervalued US stocks list
Our undervalued US stocks list holds 71 names as of 17 November 2026, ranked from 1 to 71. 42 have a score out of 100 and come first, by that score. 29 passed the screen but are not graded yet. Each has rising earnings while its price sits below its own history.
| Rank | Company | Industry | Score | Tier | Price alert | vs S&P 500, 13 weeks | Market value |
|---|---|---|---|---|---|---|---|
| 1 | Autodesk, Inc.Technology | Technology | 75.6 | B | armed | +7.9 pts | $55.3B |
| 2 | Five Below, Inc.Consumer Discretionary | Consumer Discretionary | 75.2 | B | alert live | +3.71 pts | $13.6B |
| 3 | DexCom, Inc.Healthcare | Healthcare | 73.5 | B | basing | −4.32 pts | $31.1B |
| 4 | Remitly Global, Inc.Technology | Technology | 68.6 | B | basing | −18.68 pts | $4.8B |
| 5 | Equinix, Inc.Real Estate | Real Estate | 68.3 | B | basing | −1.55 pts | $104.3B |
| 6 | Qorvo, Inc.Technology | Technology | 67.8 | B | basing | +27.04 pts | $10.1B |
| 7 | Waste Connections, Inc.Industrials | Industrials | 67.1 | C | alert live | +19.48 pts | $48.5B |
| 8 | MediaAlpha, Inc.Communication Services | Communication Services | 66.6 | B | alert live | +16.71 pts | $0.8B |
| 9 | Columbia Financial, Inc.Financials | Financials | 66 | B | basing | −2.86 pts | – |
| 10 | PTC Inc.Technology | Technology | 64.2 | C | alert live | +33.71 pts | $21.3B |
| 11 | Boston Scientific CorporationHealthcare | Healthcare | 64.2 | B | basing | −11.62 pts | $64.3B |
| 12 | LiveRamp Holdings, Inc.Technology | Technology | 63.9 | B | basing | +0.5 pts | $2.3B |
| 13 | Roper Technologies, Inc.Technology | Technology | 63.5 | B | alert live | +23.02 pts | $47.5B |
| 14 | Fomento Económico Mexicano, S.A.B. de C.V. (FEMSA)Consumer Staples | Consumer Staples | 62.6 | C | alert live | +14.36 pts | $40.3B |
| 15 | Cognizant Technology Solutions CorporationTechnology | Technology | 62.3 | B | alert live | +10.01 pts | $28.2B |
| 16 | Broadridge Financial Solutions, Inc.Technology | Technology | 62 | B | alert live | +15.37 pts | $21.8B |
| 17 | Monster Beverage CorporationConsumer Staples | Consumer Staples | 61.8 | B | alert live | +2.06 pts | $90.9B |
| 18 | Bio-Techne CorporationHealthcare | Healthcare | 61.7 | C | alert live | +3.38 pts | $11.4B |
| 19 | LATAM Airlines Group S.A.Industrials | Industrials | 61.7 | B | basing | −6.62 pts | $13.6B |
| 20 | Nutanix, Inc.Technology | Technology | 61.3 | B | basing | −6.52 pts | $16.3B |
| 21 | SouthState Bank CorporationFinancials | Financials | 61.1 | B | basing | −3.43 pts | $10.1B |
| 22 | Fair Isaac CorporationTechnology | Technology | 61 | B | basing | −30.84 pts | $15.4B |
| 23 | Dollar General CorporationConsumer Staples | Consumer Staples | 59.8 | B | alert live | +11.64 pts | $29.6B |
| 24 | Tradeweb Markets Inc.Financials | Financials | 59.1 | B | alert live | +27.71 pts | $30.8B |
| 25 | Wise Group plcTechnology | Technology | 58.9 | C | basing | −11.38 pts | $11.4B |
| 26 | Salesforce, Inc.Technology | Technology | 58.1 | B | basing | +13.85 pts | $179.3B |
| 27 | TransUnionFinancials | Financials | 58 | C | basing | +3.56 pts | $15.5B |
| 28 | TPG Inc.Financials | Financials | 57.8 | C | basing | −6.16 pts | $18.6B |
| 29 | Kenvue Inc.Consumer Staples | Consumer Staples | 57.6 | B | basing | −0.8 pts | $37.1B |
| 30 | The Cigna GroupHealthcare | Healthcare | 56.8 | C | alert live | +7.94 pts | $78.3B |
| 31 | GameStop Corp.Consumer Discretionary | Consumer Discretionary | 56.3 | C | alert live | +41.36 pts | $13.0B |
| 32 | Bristol-Myers Squibb CompanyHealthcare | Healthcare | 56.2 | C | armed | +2.2 pts | $129.7B |
| 33 | Amcor plcConsumer Discretionary | Consumer Discretionary | 54.9 | C | basing | −2.01 pts | $20.2B |
| 34 | StandardAero, Inc.Industrials | Industrials | 54.8 | B | basing | +2.22 pts | $8.9B |
| 35 | Ironwood Pharmaceuticals, Inc.Healthcare | Healthcare | 54.5 | C | alert live | +17.87 pts | $0.7B |
| 36 | Aon plcFinancials | Financials | 53.9 | B | basing | −2.09 pts | $71.8B |
| 37 | Pinnacle Financial Partners, Inc.Financials | Financials | 52.9 | C | basing | −3.61 pts | $15.2B |
| 38 | Eversource EnergyUtilities | Utilities | 50.9 | B | basing | +1.96 pts | $27.0B |
| 39 | SBA Communications CorporationReal Estate | Real Estate | 49.3 | B | basing | +5.07 pts | $19.8B |
| 40 | Franklin Resources, Inc. (renaming to Franklin Templeton, Inc. effective August 17, 2026)Financials | Financials | 48 | C | alert live | +9.21 pts | $18.4B |
| 41 | Tetra Tech, Inc.Industrials | Industrials | 44.1 | C | alert live | +9.18 pts | $9.8B |
| 42 | Super Micro Computer, Inc.Technology | Technology | 40.2 | C | basing | −29.74 pts | $17.7B |
| 43 | Alnylam Pharmaceuticals, Inc.Healthcare | Healthcare | – | Not graded | basing | −24.99 pts | $22.1B |
| 44 | Albemarle CorporationMaterials | Materials | – | Not graded | basing | −28.47 pts | $11.0B |
| 45 | Grab HoldingsTechnology | Technology | – | Not graded | basing | −7.67 pts | $13.1B |
| 46 | Sociedad Química y Minera de Chile S.A.Materials | Materials | – | Not graded | basing | −25.04 pts | $15.3B |
| 47 | Venture Global, Inc.Energy | Energy | – | Not graded | basing | −3.25 pts | $32.9B |
| 48 | MKS Inc.Technology | Technology | – | Not graded | basing | −27.77 pts | $14.6B |
| 49 | UDR, Inc.Real Estate | Real Estate | – | Not graded | basing | −1.12 pts | $12.3B |
| 50 | Camden Property TrustReal Estate | Real Estate | – | Not graded | basing | −7.33 pts | $10.1B |
| 51 | CVS Health CorporationHealthcare | Healthcare | – | Not graded | basing | −5.21 pts | $114.3B |
| 52 | United Microelectronics CorporationTechnology | Technology | – | Not graded | basing | −18.55 pts | $38.7B |
| 53 | Vishay Intertechnology, Inc.Technology | Technology | – | Not graded | basing | −15.51 pts | $3.6B |
| 54 | Occidental Petroleum CorporationEnergy | Energy | – | Not graded | basing | +3.5 pts | $58.7B |
| 55 | On Holding AGConsumer Discretionary | Consumer Discretionary | – | Not graded | basing | +7.21 pts | $11.2B |
| 56 | BP p.l.c.Energy | Energy | – | Not graded | basing | +10.28 pts | $117.5B |
| 57 | Ingersoll Rand Inc.Industrials | Industrials | – | Not graded | basing | +4.89 pts | $32.7B |
| 58 | FabrinetTechnology | Technology | – | Not graded | basing | −39.65 pts | $11.7B |
| 59 | Futu HoldingsFinancials | Financials | – | Not graded | basing | −6.18 pts | $13.4B |
| 60 | Applied Materials, Inc.Technology | Technology | – | Not graded | basing | −24.12 pts | $294.0B |
| 61 | Archer-Daniels-Midland CompanyConsumer Staples | Consumer Staples | – | Not graded | basing | −6.55 pts | $34.7B |
| 62 | Alcoa CorporationMaterials | Materials | – | Not graded | basing | −17.66 pts | $10.5B |
| 63 | KKR & Co. Inc.Financials | Financials | – | Not graded | basing | −11.17 pts | $87.5B |
| 64 | Yum! Brands, Inc.Consumer Discretionary | Consumer Discretionary | – | Not graded | basing | +11.76 pts | $43.3B |
| 65 | LPL Financial Holdings Inc.Financials | Financials | – | Not graded | basing | −18.27 pts | $22.8B |
| 66 | First Solar, Inc.Technology | Technology | – | Not graded | basing | −24.27 pts | $18.4B |
| 67 | Nu HoldingsFinancials | Financials | – | Not graded | basing | −10.37 pts | $64.0B |
| 68 | Blackstone Inc.Financials | Financials | – | Not graded | basing | −13.66 pts | $149.4B |
| 69 | Ally Financial Inc.Financials | Financials | – | Not graded | basing | −11.87 pts | $11.5B |
| 70 | PepsiCo, Inc.Consumer Staples | Consumer Staples | – | Not graded | basing | +6.13 pts | $198.2B |
| 71 | Neurocrine Biosciences, Inc.Healthcare | Healthcare | – | Not graded | basing | +12.44 pts | $16.9B |
United States · against the S&P 500 (SPY) · quality ranking updated weekly for names whose price is moving · latest read 16 Nov 2026 · prices and alerts refreshed weekly · data as of 17 Nov 2026
Which deep value stocks have a price alert this week?
8 names on our undervalued US list had a live price alert and 1 was armed in the week to 17 November 2026. A live alert means two weekly closes above both the 50-day and 200-day averages while beating the S&P 500 (SPY) over 13 weeks.
Price alerts, bullish now · 2 weekly closes: price above both its 50- and 200-day averages and beating S&P 500 (SPY) over 13 weeks (S&P 500 (SPY) 13 weeks -4.35%)
| Company | Alert | Grade | vs S&P 500, 13 weeks | Weeks firing |
|---|---|---|---|---|
| Five Below, Inc. | fired | B·75 | +3.71 pts | firing 2w |
| MediaAlpha, Inc. | fired | B·67 | +16.71 pts | firing 4w |
| Roper Technologies, Inc. | fired | B·64 | +23.02 pts | firing 3w |
| Cognizant Technology Solutions Corporation | fired | B·62 | +10.01 pts | firing 4w |
| Broadridge Financial Solutions, Inc. | fired | B·62 | +15.37 pts | firing 4w |
| Monster Beverage Corporation | fired | B·62 | +2.06 pts | firing 2w |
| Dollar General Corporation | fired | B·60 | +11.64 pts | firing 2w |
| Tradeweb Markets Inc. | fired | B·59 | +27.71 pts | firing 1w |
| Autodesk, Inc. | armed | B·76 | +7.9 pts | – |
FIRED = both weeks confirmed. ARMED = one week in place, watch next Friday. Tier C names never appear here. Momentum without a real earnings curve is ignored by rule. Data as of 17 Nov 2026.
Why is each stock on the list, and how is it scored?
All 42 scored names on our undervalued US list have a card below, as of 17 November 2026. Each passed the screen when it joined: profit well up, price flat or below its 3-year high. Each card shows its quality read, three checks, data dates, weekly record against the S&P 500 (SPY) and main risk.
8 names are marked provisional. We have graded the numbers but not yet read the management record. So the last part of the score is the typical read of the names we have read (14 out of 35). The score moves either way once that name is read.
Show
Rank by
01 Autodesk, Inc.76 out of 100 · tier B · armed
Technology · market value $55.3B
- Fundamentals39.9 of 45
- Earnings curve12.7 of 20
- Management (the why)23.0 of 35
- Management credibility0
What is driving it: New transaction model (annual billing replacing upfront multi-year billing through distributors) · Main risk: Contracted backlog shrinking relative to revenue: Autodesk is winding down discounted multi-year contracts. So unbilled deferred revenue fell 8% and total RPO grew only 2% while revenue grew 16%. If customers do not renew at the higher prices, future revenue growth has less contracted support.
Promise audit: pending: Fiscal 27 revenue guidance raised to a range of $8.295 billion to $8.345 billion · pending: Fiscal 27 billings guidance raised to a range of $8.575 billion to $8.
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings +82%. Price +22% over the same three years.
- Profit source: unknown. Other income is missing for 31 Oct 2025, 31 Jan 2026, 30 Apr 2026, 31 Jul 2026, so the share cannot be worked out. · Aug 2025 to Jul 2026 · 4 quarters
- Cash backing: supported. Operating cash 179.6% of profit. Latest quarter 116.9% · Oct 2024 to Jul 2026 · 8 quarters
- Capital returns: supported, ROCE 24.4% → 34.2% · Jul 2025 to Jul 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 31 Jul 2026 · Cash through 31 Jul 2026 · Ratios through 31 Jul 2026 · Research dated 16 Nov 2026
Autodesk, Inc.: price and its 200-day average every fourth week, last 52 weeks
- Price $264.42
- 200-day average $233.82
| Week | Price | 200-day average |
|---|---|---|
| 12 Dec 2025 | $297.64 | $293.33 |
| 9 Jan 2026 | $276.02 | $296.18 |
| 6 Feb 2026 | $240.40 | $296.19 |
| 6 Mar 2026 | $260.99 | $291.88 |
| 2 Apr 2026 | $238.08 | $286.96 |
| 1 May 2026 | $244.35 | $280.46 |
| 29 May 2026 | $231.31 | $274.96 |
| 26 Jun 2026 | $196.26 | $266.47 |
| 24 Jul 2026 | $209.75 | $255.69 |
| 21 Aug 2026 | $253.83 | $249.45 |
| 18 Sep 2026 | $216.95 | $243.50 |
| 16 Oct 2026 | $239.90 | $235.73 |
| 13 Nov 2026 | $264.42 | $233.82 |
Autodesk, Inc.: earnings per share over the last 12 months, at each of 18 quarters
| Quarter | Earnings per share, last 12 months |
|---|---|
| Apr 2022 | $2.21 |
| Jul 2022 | $2.54 |
| Oct 2022 | $2.83 |
| Jan 2023 | $3.79 |
| Apr 2023 | $3.87 |
| Jul 2023 | $4.05 |
| Oct 2023 | $4.26 |
| Jan 2024 | $4.2 |
| Apr 2024 | $4.61 |
| Jul 2024 | $4.88 |
| Oct 2024 | $5.03 |
| Jan 2025 | $5.12 |
| Apr 2025 | $4.66 |
| Jul 2025 | $4.82 |
| Oct 2025 | $5.15 |
| Jan 2026 | $5.24 |
| Apr 2026 | $6.86 |
| Jul 2026 | $7.73 |
P/E at each quarter: Apr 2022 85.6× · Jul 2022 97.8× · Oct 2022 85.1× · Jan 2023 74.5× · Apr 2023 51.5× · Jul 2023 54.3× · Oct 2023 48.2× · Jan 2024 59.5× · Apr 2024 51.9× · Jul 2024 52.3× · Oct 2024 58.6× · Jan 2025 60.8× · Apr 2025 52.7× · Jul 2025 65.1× · Oct 2025 58.5× · Jan 2026 49.1× · Apr 2026 45.3× · Jul 2026 34.2×
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 13 of 20 ahead
Against the S&P 500 (SPY): 13 weeks +7.9 pts · 1 year −23.95 pts · 3 years −45.68 pts
The earnings rise is real and cash-backed. Revenue grew 16% with GAAP operating margin up about four points, and management's explanations match hard numbers in the filings. But the contracted backlog is growing only 2% while revenue grows 16%, which is the clearest reason the current pace could fade. This read is wrong if fiscal 27 revenue comes in below the raised guidance floor of $8.295 billion. Or if reported revenue growth runs below 10% year-on-year for two consecutive quarters, either would show.
02 Five Below, Inc.75 out of 100 · tier B · alert live
Consumer Discretionary · market value $13.6B
- Fundamentals42.8 of 45
- Earnings curve10.4 of 20
- Management (the why)22.0 of 35
- Management credibility0
What is driving it: New store openings · Main risk: Tariff reversal assumption: the full-year outlook assumes tariff rates revert to start-of-fiscal-year levels after July 24, 2026. If higher rates persist, the cost base of an imported, mostly $1-5 assortment is directly hit.
Promise audit: pending: the second quarter of fiscal 2026 net sales of $1.18-1.20 billion, comparable sales up approximately 7-9%. Approximately 50 new stores, net income of $64-71 million, diluted EPS of $1.15-1.27.
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings +131%. Price +36% over the same three years.
- Profit source: unknown. Other income is missing for 1 Nov 2025, 31 Jan 2026, 2 May 2026, 1 Aug 2026, so the share cannot be worked out. · Aug 2025 to Aug 2026 · 4 quarters
- Cash backing: supported. Operating cash 152.7% of profit. Latest quarter 97.3% · Nov 2024 to Aug 2026 · 8 quarters
- Capital returns: supported, ROCE 9.5% → 14.5% · Aug 2025 to Aug 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 1 Aug 2026 · Cash through 1 Aug 2026 · Ratios through 1 Aug 2026 · Research dated 2 Sep 2026
Five Below, Inc.: price and its 200-day average every fourth week, last 52 weeks
- Price $246.68
- 200-day average $220.62
| Week | Price | 200-day average |
|---|---|---|
| 12 Dec 2025 | $183.41 | $124.98 |
| 9 Jan 2026 | $195.57 | $134.95 |
| 6 Feb 2026 | $202.61 | $147.02 |
| 6 Mar 2026 | $215.28 | $159.25 |
| 2 Apr 2026 | $235.39 | $169.16 |
| 1 May 2026 | $230.52 | $179.31 |
| 29 May 2026 | $227.36 | $187.13 |
| 26 Jun 2026 | $188.37 | $192.13 |
| 24 Jul 2026 | $203.19 | $195.83 |
| 21 Aug 2026 | $250.24 | $203.43 |
| 18 Sep 2026 | $234.14 | $212.18 |
| 16 Oct 2026 | $222.72 | $216.24 |
| 13 Nov 2026 | $246.68 | $220.62 |
Five Below, Inc.: earnings per share over the last 12 months, at each of 18 quarters
| Quarter | Earnings per share, last 12 months |
|---|---|
| Apr 2022 | $4.66 |
| Jul 2022 | $4.25 |
| Oct 2022 | $4.11 |
| Jan 2023 | $4.69 |
| Apr 2023 | $4.77 |
| Jul 2023 | $4.87 |
| Oct 2023 | $4.84 |
| Feb 2024 | $5.41 |
| May 2024 | $5.31 |
| Aug 2024 | $5.07 |
| Nov 2024 | $4.84 |
| Feb 2025 | $4.6 |
| May 2025 | $4.77 |
| Aug 2025 | $4.94 |
| Nov 2025 | $5.57 |
| Jan 2026 | $6.47 |
| May 2026 | $7.93 |
| Aug 2026 | $11.15 |
P/E at each quarter: Apr 2022 33.7× · Jul 2022 27.3× · Oct 2022 35.2× · Jan 2023 47.5× · Apr 2023 42.1× · Jul 2023 43.5× · Oct 2023 34.9× · Feb 2024 37.4× · May 2024 26.8× · Aug 2024 13× · Nov 2024 18.9× · Feb 2025 19.4× · May 2025 18.3× · Aug 2025 27.9× · Nov 2025 31.8× · Jan 2026 34.4× · May 2026 35.6× · Aug 2026 22.1×
Weeks against the S&P 500 (SPY), last 20: beating 5 wks · 12 of 20 ahead · alert firing 2 wks
Against the S&P 500 (SPY): 13 weeks +3.71 pts · 1 year +55.48 pts · 3 years −31.32 pts
The earnings rise is real in the reported numbers. 22.7% comparable sales plus 7.9% more stores roughly tripled operating income to $154.2 million. But the supplied documents prove the result far better than they prove management's explanation of it. And the margin story rests on one extraordinary quarter. The second quarter of fiscal 2026 report (quarter ending about August 1, 2026, expected around late August/early September 2026). If comparable sales come in below the guided 7% floor or net income below the guided $64 million, the first quarter.
03 DexCom, Inc.74 out of 100 · tier B · basing
Healthcare · market value $31.1B
- Fundamentals41.1 of 45
- Earnings curve12.4 of 20
- Management (the why)20.0 of 35
- Management credibility+2
What is driving it: Stelo / type-2 non-insulin consumer CGM expansion · Main risk: Revenue growth deceleration: year-over-year reported growth fell from 22% in the third quarter-2025 to 13% in the second quarter-2026.
Promise audit: done: the fiscal 2025 revenue of $4.630-4.650 billion (approximately 15% growth). Non-GAAP gross margin about 61%, non-GAAP operating margin 20-21%, adjusted operating margin 29-30%…
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings +181%. Price −21% over the same three years.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 167.2% of profit. Latest quarter 118.4% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: supported, ROCE 18.7% → 30.7% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 2 Sep 2026
DexCom, Inc.: price and its 200-day average every fourth week, last 52 weeks
- Price $83.33
- 200-day average $75.08
| Week | Price | 200-day average |
|---|---|---|
| 12 Dec 2025 | $66.96 | $74.50 |
| 9 Jan 2026 | $67.40 | $73.75 |
| 6 Feb 2026 | $69.97 | $74.24 |
| 6 Mar 2026 | $68.10 | $73.50 |
| 2 Apr 2026 | $62.22 | $71.64 |
| 1 May 2026 | $61.35 | $69.49 |
| 29 May 2026 | $73.74 | $67.83 |
| 26 Jun 2026 | $70.14 | $67.27 |
| 24 Jul 2026 | $71.54 | $67.50 |
| 21 Aug 2026 | $92.34 | $69.32 |
| 18 Sep 2026 | $89.35 | $72 |
| 16 Oct 2026 | $86.04 | $73.97 |
| 13 Nov 2026 | $83.33 | $75.08 |
DexCom, Inc.: earnings per share over the last 12 months, at each of 19 quarters
| Quarter | Earnings per share, last 12 months |
|---|---|
| Mar 2022 | $0.62 |
| Jun 2022 | $0.55 |
| Sep 2022 | $0.59 |
| Dec 2022 | $0.82 |
| Mar 2023 | $0.71 |
| Jun 2023 | $0.86 |
| Sep 2023 | $0.91 |
| Dec 2023 | $1.31 |
| Mar 2024 | $1.55 |
| Jun 2024 | $1.62 |
| Sep 2024 | $1.67 |
| Dec 2024 | $1.42 |
| Mar 2025 | $1.33 |
| Jun 2025 | $1.43 |
| Sep 2025 | $1.8 |
| Dec 2025 | $2.09 |
| Mar 2026 | $2.34 |
| Jun 2026 | $2.53 |
| Sep 2026 | $2.55 |
P/E at each quarter: Mar 2022 194× · Jun 2022 125× · Sep 2022 137× · Dec 2022 192× · Mar 2023 163× · Jun 2023 149× · Sep 2023 108× · Dec 2023 137× · Mar 2024 106× · Jun 2024 73.2× · Sep 2024 41.5× · Dec 2024 48.1× · Mar 2025 47.6× · Jun 2025 64.8× · Sep 2025 47× · Dec 2025 37.6× · Mar 2026 29.7× · Jun 2026 30× · Sep 2026 32.7×
Weeks against the S&P 500 (SPY), last 20: beating 1 wk · 9 of 20 ahead
Against the S&P 500 (SPY): 13 weeks −4.32 pts · 1 year +31.25 pts · 3 years −87.96 pts
The earnings rise is real. 13% revenue growth and a 24.3% GAAP operating margin are confirmed in official results with $1.95B of cash and an undrawn revolver. But the press releases document the recovery better than they explain it (no sourced cause for the 5.9 percentage points margin jump). And growth has decelerated from 22%. Year-over-year revenue growth below roughly 8% for two consecutive quarters. Or GAAP operating margin falling back below roughly 15%, in results reported through the third quarter-2026 earnings release (expected late October 2026).
04 Remitly Global, Inc.69 out of 100 · tier B · basing
Technology · market value $4.8B
- Fundamentals30.9 of 45
- Earnings curve13.7 of 20
- Management (the why)24.0 of 35
- Management credibility0
What is driving it: High Value Senders mix shift (individuals sending $5,000 or more per transaction) · Main risk: Headline net income overstates the run-rate. $140.6m of the $205.9m the second quarter of fiscal 2026 profit is a one-time tax benefit that will not repeat.
Promise audit: pending: Full-year 2026 revenue of $1.978b–$1.988b, 21% to 22% YoY growth · pending: Full-year 2026 Adjusted operating profit of $410m–$415m at a 21% Adjusted operating margin
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings +1745%. Price +60% over the same year.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 170.8% of profit. Latest quarter 137.7% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: supported, ROCE 4.1% → 19.6% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 17 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 26 Oct 2026
Remitly Global, Inc.: price and its 200-day average every fourth week, last 52 weeks
- Price $20.53
- 200-day average $21.11
| Week | Price | 200-day average |
|---|---|---|
| 19 Dec 2025 | $14.62 | $18.08 |
| 16 Jan 2026 | $13.75 | $17.48 |
| 13 Feb 2026 | $12.76 | $16.87 |
| 13 Mar 2026 | $15.25 | $16.30 |
| 10 Apr 2026 | $16.86 | $15.86 |
| 8 May 2026 | $24.03 | $16.18 |
| 5 Jun 2026 | $18.77 | $16.50 |
| 2 Jul 2026 | $23.75 | $16.67 |
| 31 Jul 2026 | $22.77 | $17.40 |
| 28 Aug 2026 | $26.55 | $18.36 |
| 25 Sep 2026 | $21.36 | $19.34 |
| 23 Oct 2026 | $24.82 | $20.27 |
| 17 Nov 2026 | $20.53 | $21.11 |
Weeks against the S&P 500 (SPY), last 20: 4 wks since beat · 9 of 20 ahead
Against the S&P 500 (SPY): 13 weeks −18.68 pts · 1 year +56.43 pts · 3 years −69.5 pts
The earnings rise is real at the operating level. Revenue up 20% and operating income up from $14.6m to $66.7m in a year. With management naming the causes (more active customers and send volume, better network economics, AI-driven cost cuts). But the $205.9m headline quarterly profit is mostly a one-time $140. The third quarter of fiscal 2026 revenue coming in below the $505m guidance floor. Or operating margin falling back toward the roughly 3% level of mid-2025, would show the margin inflection is not durable.
05 Equinix, Inc.68 out of 100 · tier B · basing
Real Estate · market value $104.3B
- Fundamentals33.8 of 45
- Earnings curve10.6 of 20
- Management (the why)24.0 of 35
- Management credibility+2
What is driving it: Deliver the fiscal 2026 guidance: revenue of $10.123-10.223 billion (+10-11% as reported). Adjusted operating margin of about 51% (a 200 basis-point expansion), AFFO per share of $41.93-42.74 · Main risk: Debt-funded growth: senior notes, interest expense and capex are all rising faster than revenue. And the company spent $2,575 million net on spending on H1 2026 against $1,784 million of operating cash flow
Promise audit: missed: the first quarter 2026 revenues of $2.496-2.536 billion (including a $20 million FX benefit) · pending: the fiscal 2026 revenues of $10.123-10.223 billion, adjusted operating profit of $5.141-5.
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Earnings +79%. Price +36% over the same three years. Research kept: the price is not compressed against its own history today.
- Profit source: not applicable. This is a property company.
- Cash backing: not applicable. This is a property company.
- Capital returns: supported, ROE 7.7% → 11.5% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 5 Nov 2026
Equinix, Inc.: price and its 200-day average every fourth week, last 52 weeks
- Price $1,054
- 200-day average $1,022
| Week | Price | 200-day average |
|---|---|---|
| 12 Dec 2025 | $750.32 | $812.25 |
| 9 Jan 2026 | $800.35 | $803.69 |
| 6 Feb 2026 | $848.12 | $805.05 |
| 6 Mar 2026 | $937.20 | $812.36 |
| 2 Apr 2026 | $1,000 | $820.07 |
| 1 May 2026 | $1,085 | $846.50 |
| 29 May 2026 | $1,068 | $873.77 |
| 26 Jun 2026 | $1,091 | $902.31 |
| 24 Jul 2026 | $1,084 | $925.49 |
| 21 Aug 2026 | $1,065 | $949.15 |
| 18 Sep 2026 | $1,021 | $973.19 |
| 16 Oct 2026 | $985.98 | $1,000 |
| 13 Nov 2026 | $1,054 | $1,022 |
Weeks against the S&P 500 (SPY), last 20: beating 3 wks · 8 of 20 ahead
Against the S&P 500 (SPY): 13 weeks −1.55 pts · 1 year +21.87 pts · 3 years −31.31 pts
The earnings rise is real. Revenue up 13% in the first half of 2026 with operating income up 30%, on record AI-driven bookings. But it is acquired with borrowed money, and management already missed its own first quarter 2026 revenue guidance, so confidence rests on full-year delivery. The fiscal 2026 revenue comes in below the guided $10.123 billion low end, or AFFO per share falls below the guided $41.93. That would show the AI-driven bookings surge is not converting into recurring revenue and this read.
06 Qorvo, Inc.68 out of 100 · tier B · basing
Technology · market value $10.1B
- Fundamentals30.4 of 45
- Earnings curve12.4 of 20
- Management (the why)25.0 of 35
- Management credibility+2
What is driving it: Gross-margin expansion from revenue-mix optimization within and across segments plus cost and productivity initiatives · Main risk: Merger regulatory risk: the FTC issued a Second Request on February 5, 2026. Extending the HSR waiting period for the Skyworks deal that now carries the forward story. Failure would trigger a $298.7 million termination fee (or $100.0 million antitrust-failure fee from Skyworks to Qorvo).
Promise audit: management says done, not proved by the numbers: December 2025 quarter. Revenue approximately $985 million plus or minus $50 million, non-GAAP gross margin between 47% and 49%.
Why it qualifies: data incomplete · checks as of 18 Nov 2026
No usable current price.
- Profit source: unknown. Other income is missing for 27 Sep 2025, 27 Dec 2025, 28 Mar 2026, 27 Jun 2026, so the share cannot be worked out. · Jun 2025 to Jun 2026 · 4 quarters
- Cash backing: supported. Operating cash 310.3% of profit. Latest quarter 162.6% · Sep 2024 to Jun 2026 · 8 quarters
- Capital returns: supported, ROCE 7.3% → 12.1% · Jun 2025 to Jun 2026 · 5 quarterly readings
Earnings through 27 Jun 2026 · Cash through 27 Jun 2026 · Ratios through 27 Jun 2026 · Research dated 6 Sep 2026
Weeks against the S&P 500 (SPY), last 20: 2 wks since beat · 8 of 20 ahead · alert firing 5 wks
Against the S&P 500 (SPY): 13 weeks +27.04 pts · 1 year +7.13 pts · 3 years −58.78 pts
The earnings jump is real and management has proven why. Gross margin expanded from 40.5% to 51.1% (GAAP, year-over-year in the June 2026 quarter) through revenue-mix optimization. And cost/productivity execution, confirmed across two guidance cycles. But it happened on shrinking revenue, and the forward story is now. Two measurable conditions would break this read. (1) the Skyworks merger is blocked. Or terminated (watch the FTC Second Request process and the exchange offers open until September 1, 2026), which removes the forward.
07 Waste Connections, Inc.67 out of 100 · tier C · alert live
Industrials · market value $48.5B
- Fundamentals39.9 of 45
- Earnings curve13.2 of 20
- Management (the why)14.0 of 35
- Management credibility0
What is driving it: Price-led solid waste organic growth converting into margin · Main risk: Recurring impairment and environmental charges eroding the reported margin story
Promise audit: pending: 2026 revenue of $9.90 billion to $9.95 billion · pending: 2026 net income of $1.223 billion to $1.238 billion and adjusted operating profit of $3.300 billion to $3.325 billion
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings +39%. Price +44% over the same three years.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 282.2% of profit. Latest quarter 192.6% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: supported, ROCE 6.8% → 9.9% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 3 Nov 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 5 of 20 ahead · alert firing 1 wk
Against the S&P 500 (SPY): 13 weeks +19.48 pts · 1 year +2.76 pts · 3 years −23.49 pts
The earnings rise is real. Price-led solid waste growth converting into expanding adjusted margins and strong cash. But the qualitative case rests on a single management-voice document plus numeric filings, so confidence is capped at very thin history. Full-year 2026 revenue below $9.90 billion or adjusted operating profit below $3.300 billion. The bottom of the company's own guidance (web:5). Would break the momentum read. The next checks are the fiscal 2026 results release and 10-K, expected.
08 MediaAlpha, Inc.67 out of 100 · tier B · alert live
Communication Services · market value $0.8B
- Fundamentals25.3 of 45
- Earnings curve11.3 of 20
- Management (the why)30.0 of 35
- Management credibility+5
What is driving it: P&C carrier advertising demand broadening beyond the top two spenders · Main risk: P&C advertising cycle turns. MediaAlpha's revenue is a toll on insurance carriers' ad budgets, which swell when carriers fight for customers and get cut when the market settles. Management itself flags the soft-market dynamic (web:2). And the 10-Q lists 'Fluctuations in customer acquisition spending by property and casualty insurance carriers' as a lead risk (web:1).
Promise audit: done: the first quarter-2026 guidance: Transaction Value $570-595M (up about 23% at midpoint, P&C ~+35%). Revenue $285-305M. Adjusted operating profit $29.5-31.5M.
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings +1051%. Price +22% over the same two years.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 133.5% of profit. Latest quarter 83.9% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: mixed, ROCE 108.1% → 41.5% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 17 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 1 Nov 2026
Weeks against the S&P 500 (SPY), last 20: beating 2 wks · 9 of 20 ahead · alert firing 4 wks
Against the S&P 500 (SPY): 13 weeks +16.71 pts · 1 year +8.06 pts · 3 years −9.59 pts
The earnings rise is real and operationally driven. Property-and-casualty insurance carriers accelerated advertising spend, MediaAlpha took share, and its last two quarterly guides were beaten on both revenue and profit. But the headline June-2026 net income of $41.8M was mostly a one-time $37.7M tax-agreement gain. P&C revenue growth below 10% year over year for two consecutive quarters. Or the quarterly take rate falling below the fourth quarter-2025's 7.6% while Open Marketplace stays above 98% of revenue. Either would show the carrier.
09 Columbia Financial, Inc.66 out of 100 · tier B · basing
Financials
- Fundamentals29.8 of 45
- Earnings curve13.2 of 20
- Management (the why)23.0 of 35
- Management credibility+2
What is driving it: Deposit and borrowing repricing after the 2025 rate cuts, extending the margin expansion begun by the 2024 repositioning · Main risk: New Jersey commercial real estate credit deterioration
Promise audit: done: The fourth quarter 2024 balance-sheet repositioning (divest low-yield securities, prepay high-cost borrowings, absorb a $37.9M pre-tax loss) would improve net interest margin ·
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings −3%. Price −38% over the same three years.
- Profit source: not applicable. This is a bank, lender or insurer.
- Cash backing: not applicable. This is a bank, lender or insurer.
- Capital returns: supported, ROE 1.3% → 2.3% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 17 Nov 2026 · Earnings through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 2 Sep 2026
Weeks against the S&P 500 (SPY), last 20: beating 1 wk · 12 of 20 ahead
Against the S&P 500 (SPY): 13 weeks −2.86 pts · 1 year +50.82 pts · 3 years −100.39 pts
The earnings rise is real and well-explained. A deliberately disclosed 2024 balance-sheet repositioning plus falling deposit costs lifted net interest margin from 1.88% to 2.42% over five quarters. While credit costs fell. But only two usable documents cap confidence in the record. Net interest margin fails to rise for two consecutive quarters (flat or down QoQ) while non-performing loans climb past roughly 0.6% of gross loans. That would show the deposit-repricing tailwind is spent and NJ CRE.
10 PTC Inc.64 out of 100 · tier C · alert live
Technology · market value $21.3B
- Fundamentals34.9 of 45
- Earnings curve15.3 of 20
- Management (the why)14.0 of 35
- Management credibility+7
What is driving it: Recurring ARR growth from the go-to-market transformation and AI-driven customer demand · Main risk: Booking-quality signal: deferred revenue is shrinking (a $112.4 million decline in the December quarter and $104.7 million over nine months) even. As constant-currency ARR grows 9.1%. Under ASC 606, where a substantial portion of subscription value is recognized upfront. A slowdown in new billings would hit reported revenue and EPS hard.
Promise audit: management says done, not proved by the numbers: the third quarter'26 constant-currency ARR growth excluding divested businesses of 8% to 9% · done: the third quarter'26 operating cash flow of $255 to $260.
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Earnings +331%. Price +27% over the same three years. Research kept: recent profit is not near its best of the last twelve periods today.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 99.9% of profit. Latest quarter 30.1% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: mixed, ROCE 18.7% → 14.1% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 13 Oct 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 15 of 20 ahead · alert firing 5 wks
Against the S&P 500 (SPY): 13 weeks +33.71 pts · 1 year −3.14 pts · 3 years −40.02 pts
The cash and recurring-revenue growth look real. Constant-currency ARR up 9.1% with cash flow beating guidance two quarters running. But the headline profit jump is flattered by a one-off $463 million divestiture gain and upfront license accounting. So the durable signal is the ARR and free-cash-flow trend. Constant-currency ARR growth excluding divested businesses comes in below the 9% floor of the raised fiscal 2026 guidance at the September 30, 2026 fiscal year-end report. That single number would break.
11 Boston Scientific Corporation64 out of 100 · tier B · basing · provisional
Healthcare · market value $64.3B
- Fundamentals37.1 of 45
- Earnings curve13.1 of 20
- Management (the why)no data
- Management credibilityno data
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Earnings +189%. Price −18% over the same three years. Research kept: recent profit is not near its best of the last twelve periods today.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 140.8% of profit. Latest quarter 180.1% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: mixed, ROCE 10% → 11% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 9 Aug 2026
Weeks against the S&P 500 (SPY), last 20: beating 2 wks · 11 of 20 ahead
Against the S&P 500 (SPY): 13 weeks −11.62 pts · 1 year −69.09 pts · 3 years −85.75 pts
The graph is a genuine earnings staircase. Revenue +17.4% TTM, profit before tax +51%, 146% cash conversion, negligible SBC, debt flat on growing equity. Yet the price halved via two discrete crash days (Feb-4-26 −17.6%, May 2027-26 −12.5%). this read (B, not A) is wrong if the June 2026 quarter prints revenue growth still >=12% YoY with operating margin >=18% and no charge. That would prove the crashes were multiple compression, upgrade to A. Conversely wrong the other.
12 LiveRamp Holdings, Inc.64 out of 100 · tier B · basing
Technology · market value $2.3B
- Fundamentals33.8 of 45
- Earnings curve13.1 of 20
- Management (the why)17.0 of 35
- Management credibility0
What is driving it: Contracted subscription revenue (CRPO) converting to recognised revenue · Main risk: The Publicis merger is delayed, voted down or terminated, removing the $38.50 cash floor and forcing the shares to trade on standalone fundamentals.
Promise audit: pending: Publicis Groupe will acquire LiveRamp for $38.50 per share in cash. The transaction is expected to close before the end of calendar 2026.
Why it qualifies: data incomplete · checks as of 18 Nov 2026
Earnings +5776%. Price +37% over the same two years. No usable current price.
- Profit source: unknown. Other income is missing for 30 Sep 2025, 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, so the share cannot be worked out. · Jul 2025 to Jun 2026 · 4 quarters
- Cash backing: supported. Operating cash 194.1% of profit. Latest quarter 97.2% · Jun 2024 to Jun 2026 · 8 quarters
- Capital returns: supported, ROCE 2.6% → 10.3% · Jun 2025 to Jun 2026 · 5 quarterly readings
Earnings through 30 Jun 2026 · Cash through 30 Jun 2026 · Ratios through 30 Jun 2026 · Research dated 1 Nov 2026
Weeks against the S&P 500 (SPY), last 20: beating 3 wks · 10 of 20 ahead · alert firing 1 wk
Against the S&P 500 (SPY): 13 weeks +0.5 pts · 1 year +30.02 pts · 3 years −43.26 pts
The earnings improvement is real but modest. Revenue grew about 10% on subscription retention while falling research-and-administration costs roughly tripled GAAP operating income. But the headline profit jump is inflated by a one-time tax accounting benefit, and the share price now rests on the pending. Subscription net retention falls below 100% in the second quarter of fiscal 2027 results (due around early November 2026). That would show merger-related customer attrition is already shrinking the subscription base and would break.
13 Roper Technologies, Inc.64 out of 100 · tier B · alert live
Technology · market value $47.5B
- Fundamentals38.8 of 45
- Earnings curve13.7 of 20
- Management (the why)11.0 of 35
- Management credibility0
What is driving it: Acquisition-led growth in vertical software (CentralReach, Subsplash, and earlier Procare, Transact Campus, Syntellis) · Main risk: Rising cost of debt compressing the gap between operating growth and bottom-line growth. Net interest expense was $111.4M in the June 2026 quarter versus $79.1M a year earlier, on total debt of about $11,319.4 million.
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings −7%. Price −9% over the same three years.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 123.7% of profit. Latest quarter 169.3% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: supported, ROCE 6.9% → 7.9% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 2 Sep 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 11 of 20 ahead · alert firing 3 wks
Against the S&P 500 (SPY): 13 weeks +23.02 pts · 1 year −5.49 pts · 3 years −75.87 pts
The operating improvement is real but modest. Revenue rose 8.5% and operating income 6.6% in the latest quarter. While the headline profit tripling came mostly from a one-time $835.2 million equity financial-asset gain, not from operations. If the 10-Q for the quarter ending September 30, 2026 (due around end of October 2026) shows pre-tax profit excluding equity financial-asset gains declining year over year. While quarterly net interest expense exceeds roughly.
14 Fomento Económico Mexicano, S.A.B. de C.V. (FEMSA)63 out of 100 · tier C · alert live
Consumer Staples · market value $40.3B
- Fundamentals38.8 of 45
- Earnings curve9.8 of 20
- Management (the why)14.0 of 35
- Management credibility+2
What is driving it: OXXO Mexico traffic-led same-store sales recovery · Main risk: OXXO Brazil consolidation is loss-making and dilutes consolidated operating income.
Promise audit: pending: Restructuring efficiency and top-line benefits 'will ramp up during this year and will be fully in place for 2027 and beyond.' · management says done, not proved.
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Earnings −45%. Price +4% over the same three years. Research kept: recent profit is not near its best of the last twelve periods today.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 234.2% of profit. Latest quarter 312.9% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: supported, ROCE 11% → 14.7% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 6 Nov 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 8 of 20 ahead · alert firing 2 wks
Against the S&P 500 (SPY): 13 weeks +14.36 pts · 1 year +28 pts · 3 years −63.29 pts
The operating earnings rise is real and explained. OXXO Mexico's customer traffic went from slightly negative to its best reading in more than two years across four quarterly reports. And Coca-Cola FEMSA grew operating income double digits, but headline net income growth is flattered by one-time gains, and the newly. OXXO Mexico store traffic turns negative year over year again, or the consolidated operating margin falls back below 8% for two consecutive quarters. That would show the 2026 recovery was driven by the World Cup.
15 Cognizant Technology Solutions Corporation62 out of 100 · tier B · alert live
Technology · market value $28.2B
- Fundamentals38.8 of 45
- Earnings curve12.5 of 20
- Management (the why)11.0 of 35
- Management credibility0
What is driving it: Project Leap. An AI-led cost and productivity program · Main risk: AI cuts what clients pay for IT services, or shrinks demand for the work Cognizant supplies. The company itself flags 'the impact AI-based technologies may have on the demand for our services. Or our ability to obtain favorable pricing or other terms for our services'.
Promise audit: pending: Project Leap: 'Program introduced in the second quarter 2026 aimed at streamlining operations and improving productivity through AI-led efficiencies'.
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Earnings +34%. Price −9% over the same three years. Research kept: profit growth is below the 25% discovery rule today.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 120% of profit. Latest quarter 160.1% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: mixed, ROCE 19.6% → 20.2% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 16 Oct 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 15 of 20 ahead · alert firing 4 wks
Against the S&P 500 (SPY): 13 weeks +10.01 pts · 1 year −25.5 pts · 3 years −76.72 pts
The earnings rise is real in the reported numbers. Revenue, margin and buyback-driven EPS all improved, but the supplied filings prove the arithmetic, not management's story. The explanation sections were cut off, leaving one defined cost program (Project Leap) and heavy share buybacks as the only visible why. Revenue growth turns negative year on year. Or operating margin drops below about 14% for two straight quarters, in the results for the quarter ending September 30, 2026. That would show AI-driven pricing pressure.
16 Broadridge Financial Solutions, Inc.62 out of 100 · tier B · alert live
Technology · market value $21.8B
- Fundamentals38.3 of 45
- Earnings curve12.7 of 20
- Management (the why)11.0 of 35
- Management credibility0
What is driving it: Extending proxy voting and disclosure capabilities to tokenized securities ownership · Main risk: A large slice of the fiscal 2026 earnings is a digital-asset mark-to-market gain that can reverse with prices.
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Earnings +61%. Price +5% over the same three years. Research kept: profit growth is below the 25% discovery rule today.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 138.2% of profit. Latest quarter 98.3% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: mixed, ROCE 18.5% → 17.5% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 27 Oct 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 12 of 20 ahead · alert firing 4 wks
Against the S&P 500 (SPY): 13 weeks +15.37 pts · 1 year −27.14 pts · 3 years −62.01 pts
The reported profit rise is real in the filings. But the supplied documents show its main engine in the fiscal 2026 was a reversible digital-asset price gain plus lower interest expense rather than proven operating improvement. And no management explanation was in evidence to confirm otherwise. This read is wrong if the 10-Q for the December 2026 quarter. Due around early February 2027 based on the company's own filing pattern (the prior December-quarter 10-Q was filed 3 Feb 2026). Shows the digital-asset.
17 Monster Beverage Corporation62 out of 100 · tier B · alert live
Consumer Staples · market value $90.9B
- Fundamentals42.8 of 45
- Earnings curve10.0 of 20
- Management (the why)9.0 of 35
- Management credibility0
What is driving it: New-product expansion across the energy portfolio · Main risk: Receivables growing faster than sales could signal stretched credit terms or channel loading rather than end-demand.
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings +48%. Price −15% over the same three years.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 108.5% of profit. Latest quarter 97.9% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: mixed, ROCE 29.7% → 28.2% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 5 Nov 2026
Weeks against the S&P 500 (SPY), last 20: 2 wks since beat · 9 of 20 ahead · alert firing 2 wks
Against the S&P 500 (SPY): 13 weeks +2.06 pts · 1 year +18.04 pts · 3 years −82.55 pts
The earnings rise is real in the filed numbers. Sales up 20% and profit up 20% in the June 2026 quarter, with operating cash flow close behind and long-term debt now zero. But the supplied filings stop before the management discussion, so what is driving the growth is not proven by this evidence. This read is wrong if the fiscal 2027 third-quarter Form 10-Q shows net sales growth below 10% year over year. While accounts receivable keeps growing faster than sales. That combination would mean the growth is being.
18 Bio-Techne Corporation62 out of 100 · tier C · alert live
Healthcare · market value $11.4B
- Fundamentals35.4 of 45
- Earnings curve12.3 of 20
- Management (the why)14.0 of 35
- Management credibility+2
What is driving it: Cash acquisition by Merck KGaA at $73 per share · Main risk: Merger completion risk. The entire current valuation rests on the $73 cash acquisition closing.
Promise audit: management says done, not proved by the numbers: Divest Exosome Diagnostics (held-for-sale from June 30, 2025) and improve Diagnostics and Spatial Biology profitability.
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings −28%. Price +19% over the same three years.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 235.6% of profit. Latest quarter 258.4% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: supported, ROCE 9.3% → 11.7% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 3 Nov 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 9 of 20 ahead · alert firing 2 wks
Against the S&P 500 (SPY): 13 weeks +3.38 pts · 1 year +10.33 pts · 3 years −48.1 pts
The profit rebound is real in the reported numbers but it is a margin and one-off-charge story on flat revenue. And the shares now trade on the pending $73-a-share cash takeover by Merck KGaA rather than on standalone fundamentals. This read is wrong if the Merck KGaA acquisition is terminated or the $73 per-share price is cut. Check company press releases and SEC merger filings. Trading at about $72.7 against the $11.40 billion screen market.
19 LATAM Airlines Group S.A.62 out of 100 · tier B · basing · provisional
Industrials · market value $13.6B
- Fundamentals36.6 of 45
- Earnings curve11.1 of 20
- Management (the why)no data
- Management credibilityno data
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Earnings −62%. Price −96% over the same three years. Research kept: recent profit is not near its best of the last twelve periods today.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 254.1% of profit. Latest quarter 233.9% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: mixed, ROCE 22.1% → 18.9% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 9 Aug 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 8 of 20 ahead
Against the S&P 500 (SPY): 13 weeks −6.62 pts · 1 year −5.86 pts · 3 years −163.35 pts
The −94% 'price crush' is not pessimism. It is the Chapter 11 old-equity wipeout. Post-reorg this is a rallying stock, so the screen's depressed-price premise is void. This B-grade is wrong (up to A) if op margin stays ≥16% through two more quarters WITH fuel/FX normalizing, buybacks continue. And the total non operating income lines resolve as recurring FX noise rather than one-off.
20 Nutanix, Inc.61 out of 100 · tier B · basing
Technology · market value $16.3B
- Fundamentals30.4 of 45
- Earnings curve13.9 of 20
- Management (the why)17.0 of 35
- Management credibility0
What is driving it: Revenue growth from signed partnerships and generally-available AI products · Main risk: Stock-based pay makes the non-GAAP margin the market watches much larger than the GAAP margin that actually belongs to shareholders. The fourth quarter of fiscal 2026 non-GAAP operating margin was 26.2% against GAAP 9.2%. And stock-based compensation was $263.1 million in the first nine months of the fiscal 2026.
Promise audit: management says done, not proved by the numbers: Anticipated closing of the stock purchase agreement with Advanced Micro Devices, Inc.
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings +581%. Price −6% over the same year.
- Profit source: unknown. Other income is missing for 31 Oct 2025, 31 Jan 2026, 30 Apr 2026, 31 Jul 2026, so the share cannot be worked out. · Aug 2025 to Jul 2026 · 4 quarters
- Cash backing: supported. Operating cash 102.5% of profit. Latest quarter 24.8% · Oct 2024 to Jul 2026 · 8 quarters
- Capital returns: mixed, ROCE 9.2% → 8.9% · Jul 2025 to Jul 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 31 Jul 2026 · Cash through 31 Jul 2026 · Ratios through 31 Jul 2026 · Research dated 28 Sep 2026
Weeks against the S&P 500 (SPY), last 20: beating 1 wk · 14 of 20 ahead
Against the S&P 500 (SPY): 13 weeks −6.52 pts · 1 year −20.66 pts · 3 years −13.12 pts
The operating improvement is real. Revenue grew 12% and GAAP operating margin went from 6.8% to 9.6% in fiscal 2026. But the causal proof rests on one press release plus two clipped 10-Qs. And the headline fourth quarter net income is mostly a one-off tax accounting gain, not operations. The first quarter of fiscal 2027 revenue (quarter ending October 31, 2026) coming in below the guided $755-765 million. Or the fiscal 2027 free cash flow tracking below the $850 million floor of guidance, would break the growth-and-margin story.
21 SouthState Bank Corporation61 out of 100 · tier B · basing
Financials · market value $10.1B
- Fundamentals34.3 of 45
- Earnings curve12.8 of 20
- Management (the why)14.0 of 35
- Management credibility0
What is driving it: Post-merger share repurchases shrinking the share count · Main risk: Credit problems imported from the Independent merger book
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Earnings +35%. Price +39% over the same three years. Research kept: the price is not compressed against its own history today.
- Profit source: not applicable. This is a bank, lender or insurer.
- Cash backing: not applicable. This is a bank, lender or insurer.
- Capital returns: mixed, ROE 9.3% → 10.3% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 6 Sep 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 8 of 20 ahead
Against the S&P 500 (SPY): 13 weeks −3.43 pts · 1 year +5.44 pts · 3 years −28.6 pts
The earnings jump is real in the filings. A completed merger plus merger-charge roll-off, but the evidence window contains no management explanation of the quarterly drivers and no forward goal to test. So the qualitative case rests on the reported numbers alone. If the second quarter 2026 10-Q shows quarterly provision for credit losses above roughly $30 million for a second straight quarter. Or OREO continuing to climb from its $26.1 million level, the merger imported credit problems.
22 Fair Isaac Corporation61 out of 100 · tier B · basing · provisional
Technology · market value $15.4B
- Fundamentals34.9 of 45
- Earnings curve12.1 of 20
- Management (the why)no data
- Management credibilityno data
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings +114%. Price −31% over the same three years.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 124.5% of profit. Latest quarter 168.1% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: unknown, ROCE 91.8% → 111.9% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 9 Aug 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 8 of 20 ahead
Against the S&P 500 (SPY): 13 weeks −30.84 pts · 1 year −70.91 pts · 3 years −98.25 pts
What broke is SPECIFIC and regulatory. The mortgage-score franchise lost its guaranteed monopoly (FHFA opening conforming mortgages to a rival score) plus political pressure on FICO's aggressive royalty hikes. While the numbers show the pricing power still working (March 2026 revenue +38.7% YoY at 58.2% operating margin, 121% cash. this read is wrong if scores revenue growth stays >=20% YoY for 2 more quarters WITH no regulatory cap enacted. And rival-score mortgage adoption staying negligible, then the pessimism was generic headline fear.
23 Dollar General Corporation60 out of 100 · tier B · alert live
Consumer Staples · market value $29.6B
- Fundamentals36.6 of 45
- Earnings curve11.2 of 20
- Management (the why)12.0 of 35
- Management credibility0
What is driving it: Debt paydown cutting interest cost · Main risk: Tariffs on imported goods raising the cost of what Dollar General supplies, or forcing price increases its low-income customer may reject
Promise audit: pending: Substantial long-term U.S. Growth potential, with significant opportunities to add new Dollar General stores in existing and new markets · pending:
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings −12%. Price +11% over the same three years.
- Profit source: unknown. Other income is missing for 31 Oct 2025, 30 Jan 2026, 1 May 2026, 31 Jul 2026, so the share cannot be worked out. · Aug 2025 to Jul 2026 · 4 quarters
- Cash backing: supported. Operating cash 223.7% of profit. Latest quarter 141.8% · Nov 2024 to Jul 2026 · 8 quarters
- Capital returns: supported, ROCE 8.2% → 10% · Aug 2025 to Jul 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 31 Jul 2026 · Cash through 31 Jul 2026 · Ratios through 31 Jul 2026 · Research dated 2 Nov 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 9 of 20 ahead · alert firing 2 wks
Against the S&P 500 (SPY): 13 weeks +11.64 pts · 1 year +16.34 pts · 3 years −56.59 pts
The profit recovery is real in the reported numbers. Gross margin climbed from about 30% to about 33% and operating margin from 4.0% to 6.8% across the four window quarters. But every filing supplied was cut off before management's own explanation, so why it happened is not proven in this packet. This read is wrong if, in the next two reported quarters (through the quarter ending late October 2026). Gross margin falls back below 30% or operating margin below 4.5% for two consecutive quarters, or if long-term.
24 Tradeweb Markets Inc.59 out of 100 · tier B · alert live
Financials · market value $30.8B
- Fundamentals40.5 of 45
- Earnings curve14.6 of 20
- Management (the why)4.0 of 35
- Management credibility0
What is driving it: not stated · Main risk: A large non-operating item inflated December-2025 profit and is not decomposed in any supplied document. So the reported profit jump may overstate the operating improvement.
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Earnings +148%. Price +42% over the same three years. Research kept: recent profit is not near its best of the last twelve periods today.
- Profit source: not applicable. This is a bank, lender or insurer.
- Cash backing: not applicable. This is a bank, lender or insurer.
- Capital returns: supported, ROE 10.8% → 14.5% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 6 Nov 2026
Weeks against the S&P 500 (SPY), last 20: beating 7 wks · 14 of 20 ahead · alert firing 1 wk
Against the S&P 500 (SPY): 13 weeks +27.71 pts · 1 year +8.93 pts · 3 years −25.25 pts
The profit rise is real in the reported numbers. Quarterly revenue climbed from about $404 million to $558 million in two years and diluted EPS went from $0.55 to $0.85. But the four filings supplied contain no management explanation of why it happened. And roughly half of December-2025 pre-tax profit came. This read is wrong if year-over-year revenue growth stays below 8% for two consecutive quarters. Or if non-operating income exceeds 15% of pre-tax profit for two straight quarters without a disclosed one-off reason.
25 Wise Group plc59 out of 100 · tier C · basing
Technology · market value $11.4B
- Fundamentals33.8 of 45
- Earnings curve11.1 of 20
- Management (the why)14.0 of 35
- Management credibility+5
What is driving it: Customer and cross-border volume growth converting to transaction revenue · Main risk: Structural take-rate compression: the price per unit of volume has declined in every disclosed quarter (0.64% to 0.50% over nine quarters). And management is deliberately reinvesting operating leverage into lower prices.
Promise audit: done: the fiscal 2026 net revenue growth within the 15-20% medium-term goal range · done: the fiscal 2026 income before tax margin within the 20-25% guided range
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Research kept: profit is below the size floor today.
- Profit source: unknown, A comparable twelve months of profit could not be built from the reported periods, so the share of other income. · Oct 2025 to Sep 2026 · 2 half-years
- Cash backing: mixed. Operating cash 1365.9% of profit. Latest half year 1049.8% · Dec 2024 to Sep 2026 · 7 half years
- Capital returns: unknown, ROCE 54.8% → 53.3%, definition unproven · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 8 Sep 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 7 of 20 ahead
Against the S&P 500 (SPY): 13 weeks −11.38 pts · 1 year −20.6 pts · 3 years −40.45 pts
The earnings rise looks real. Revenue and profit growth is driven by measurable customer and volume growth plus a disclosed, deliberate take-rate trade-off. But the qualitative record here covers only two of the last four quarters, so confidence is capped. This read is wrong if the second quarter of fiscal 2027 results (due around mid-November 2026 via the company's SEC 6-K and owners.wise.com) show constant-currency net revenue growth below 15%. Or an income before tax margin trending below.
26 Salesforce, Inc.58 out of 100 · tier B · basing
Technology · market value $179.3B
- Fundamentals36.6 of 45
- Earnings curve15.5 of 20
- Management (the why)6.0 of 35
- Management credibility0
What is driving it: Share-count shrink from the debt-funded accelerated buyback (the only forward driver visible in the filings. No management-stated revenue or margin driver exists in the supplied extracts) · Main risk: Debt-funded buyback leverage: noncurrent debt jumped from $10,439m to $39,280m in a single quarter to fund buybacks. And quarterly interest expense rose from $68m to $317m, eating into the operating income that was $2,347m in the latest quarter.
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings +317%. Price −2% over the same three years.
- Profit source: unknown. Other income is missing for 31 Oct 2025, 31 Jan 2026, 30 Apr 2026, 31 Jul 2026, so the share cannot be worked out. · Aug 2025 to Jul 2026 · 4 quarters
- Cash backing: supported. Operating cash 177.2% of profit. Latest quarter 36% · Oct 2024 to Jul 2026 · 8 quarters
- Capital returns: mixed, ROCE 11.2% → 11.4% · Jul 2025 to Jul 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 31 Jul 2026 · Cash through 31 Jul 2026 · Ratios through 31 Jul 2026 · Research dated 2 Sep 2026
Weeks against the S&P 500 (SPY), last 20: 3 wks since beat · 11 of 20 ahead
Against the S&P 500 (SPY): 13 weeks +13.85 pts · 1 year −22.87 pts · 3 years −68.87 pts
The earnings rise is real in the reported numbers. Subscription revenue up double digits with operating income also up, but the evidence window contains only numeric 10-Q filings with no management commentary. So neither the cause of the growth nor management's track record on promises can be verified. This read is wrong if the second quarter of fiscal 2027 10-Q (expected around August-September 2026) shows subscription. And support revenue growth, excluding acquisitions, below roughly 6% year over year, or shows operating income declining.
27 TransUnion58 out of 100 · tier C · basing
Financials · market value $15.5B
- Fundamentals29.8 of 45
- Earnings curve14.2 of 20
- Management (the why)14.0 of 35
- Management credibility+5
What is driving it: Trans Union de Mexico acquisition · Main risk: FICO's new Mortgage Direct License Program could divert the mortgage royalty and volumes that are currently inflating growth
Promise audit: management says done, not proved by the numbers: Raised the fiscal 2025 guidance. 8 to 8.5 percent revenue growth, Adjusted Diluted EPS $4.19-$4.25, Adjusted operating margin 35.9-36.0% ·
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Earnings +258%. Price −16% over the same two years. Research kept: recent profit is not near its best of the last twelve periods today.
- Profit source: not applicable. This is a bank, lender or insurer.
- Cash backing: not applicable. This is a bank, lender or insurer.
- Capital returns: supported, ROE 9.8% → 17% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 6 Sep 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 10 of 20 ahead
Against the S&P 500 (SPY): 13 weeks +3.56 pts · 1 year −12.31 pts · 3 years −28.29 pts
The earnings recovery is real. Revenue, operating income and operating cash flow all grew across the four quarters, and management's segment-level explanations match the filed numbers. But the headline first quarter-2026 profit spike rests on a one-time $225.5M gain on acquiring control of its Mexico affiliate. And roughly 3. The fiscal 2026 organic constant-currency revenue excluding the FICO mortgage royalty comes in below the guided +5% to +6%. Or the FICO Mortgage Direct License Program diverts mortgage volumes, either would show the growth.
28 TPG Inc.58 out of 100 · tier C · basing
Financials · market value $18.6B
- Fundamentals21.9 of 45
- Earnings curve11.9 of 20
- Management (the why)24.0 of 35
- Management credibility0
What is driving it: 2026 fundraising toward the $50 billion goal · Main risk: Mark-to-market swings in capital allocation-based income can wipe out fee earnings in GAAP terms, as happened in the March 2026 quarter.
Promise audit: pending: Exceed the $50 billion fundraising goal for 2026 · pending: Step-function growth across the firm (CEO, the second quarter 2026 release)
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings +839%. Price −12% over the same year.
- Profit source: not applicable. This is a bank, lender or insurer.
- Cash backing: not applicable. This is a bank, lender or insurer.
- Capital returns: supported, ROE 9.2% → 19.2% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 5 Nov 2026
Weeks against the S&P 500 (SPY), last 20: beating 4 wks · 14 of 20 ahead
Against the S&P 500 (SPY): 13 weeks −6.16 pts · 1 year −28.88 pts · 3 years −28.83 pts
The earnings rise is real in the recurring fee business. Fee-related earnings (profit from management fees, before performance fees) grew 43% year on year with margin up from 44% to 50%. But total GAAP profit swings violently with the value of TPG's own fund marks, part of the growth was acquired through. This read is wrong if TPG's fourth-quarter 2026 results (expected around February 2027, based on the fiscal 2025 Form 10-K having been filed February 17, 2026) show full-year capital raised below $50 billion.
29 Kenvue Inc.58 out of 100 · tier B · basing · provisional
Consumer Staples · market value $37.1B
- Fundamentals31.5 of 45
- Earnings curve12.1 of 20
- Management (the why)no data
- Management credibilityno data
Why it qualifies: data incomplete · checks as of 18 Nov 2026
Earnings −7%. Price −2% over the same three years. No usable current price.
- Profit source: unknown. Other income is missing for 28 Dec 2025, 29 Mar 2026, 28 Jun 2026, 27 Sep 2026, so the share cannot be worked out. · Sep 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 155.8% of profit. Latest quarter 162.8% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: supported, ROCE 12.7% → 14.8% · Sep 2025 to Sep 2026 · 5 quarterly readings
Earnings through 27 Sep 2026 · Cash through 27 Sep 2026 · Ratios through 27 Sep 2026 · Research dated 9 Aug 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 9 of 20 ahead
Against the S&P 500 (SPY): 13 weeks −0.8 pts · 1 year +23.58 pts · 3 years −74.16 pts
The Marks question was specific-vs-real damage, and the profit and loss answers it: through the autumn-2025 Tylenol political attack. Revenue GREW +3.2% then +4.5% YoY and March 2026 delivered the best quarter since the spin. Netinc company 474, +47% YoY, OM 19.6% series high. The damage was headline-specific, not demand-specific. this read is wrong if litigation converts from headline to material liability (a reserved settlement or adverse verdict. The discount was right), or if revenue growth slips back below zero for 2 consecutive quarters.
30 The Cigna Group57 out of 100 · tier C · alert live
Healthcare · market value $78.3B
- Fundamentals38.3 of 45
- Earnings curve10.5 of 20
- Management (the why)8.0 of 35
- Management credibility0
What is driving it: not stated · Main risk: Working-capital drag from pharmacy payables: the largest single cash swing in the quarter was a $4,570 million decrease in pharmacy. And other service costs payable, cutting operating cash flow to $1,131 million from $1,920 million despite higher earnings.
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Earnings +27%. Price +5% over the same three years. Research kept: profit growth is below the 25% discovery rule today.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 149.1% of profit. Latest quarter 178.3% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: supported, ROCE 9.7% → 11.6% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 16 Sep 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 9 of 20 ahead · alert firing 3 wks
Against the S&P 500 (SPY): 13 weeks +7.94 pts · 1 year −2.13 pts · 3 years −62.23 pts
The reported earnings rise is real in the filed numbers. The first quarter 2026 operating income rose about 20% year over year. But with only a numeric 10-Q and no management commentary or guidance in the evidence window. The operating explanation for that rise and any forward driver remain unproven. If the next quarterly filing shows the pharmacy and other service costs payable outflow persisting (another decrease of roughly $2 billion or more). So that full-year operating cash flow turns negative while net income.
31 GameStop Corp.56 out of 100 · tier C · alert live
Consumer Discretionary · market value $13.0B
- Fundamentals25.9 of 45
- Earnings curve12.4 of 20
- Management (the why)18.0 of 35
- Management credibility+2
What is driving it: Continued cost containment and store-fleet optimization · Main risk: The retail top line keeps shrinking: net sales fell 18.7% year on year in the latest quarter even as profit rose.
Promise audit: done: Sale of the France operations to a strategic customer (agreement signed). · partly done: Continue the cost-discipline program through 2026.
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings +805%. Price −2% over the same two years.
- Profit source: unknown. Other income is missing for 1 Nov 2025, 31 Jan 2026, 2 May 2026, 1 Aug 2026, so the share cannot be worked out. · Aug 2025 to Aug 2026 · 4 quarters
- Cash backing: supported. Operating cash 95.7% of profit. Latest quarter 20.9% · Nov 2024 to Aug 2026 · 8 quarters
- Capital returns: supported, ROCE 1.5% → 4.7% · Aug 2025 to Aug 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 1 Aug 2026 · Cash through 1 Aug 2026 · Ratios through 1 Aug 2026 · Research dated 1 Nov 2026
Weeks against the S&P 500 (SPY), last 20: beating 2 wks · 12 of 20 ahead · alert firing 2 wks
Against the S&P 500 (SPY): 13 weeks +41.36 pts · 1 year +12.85 pts · 3 years +31.04 pts
The earnings rise is real but mostly financial, not retail: cost cuts and 727 store closures made the shrinking chain profitable. This read is wrong if the third quarter of fiscal 2027 10-Q (quarter ending around 31 Oct 2026) shows operating income back near break-even once the financial-asset marks are stripped out. Operating margin under about 5%, while net sales keep.
32 Bristol-Myers Squibb Company56 out of 100 · tier C · armed
Healthcare · market value $129.7B
- Fundamentals36.0 of 45
- Earnings curve11.2 of 20
- Management (the why)9.0 of 35
- Management credibility0
What is driving it: New-product ramp in the Growth Portfolio (Opdivo Qvantig, Camzyos, Reblozyl, Breyanzi) replacing eroding Legacy brands · Main risk: Legacy brand erosion: Revlimid quarterly sales fell from $838 million to $425 million and Pomalyst/Imnovid from $708 million to $204 million year-on-year. The second quarter of fiscal 2026 to the second quarter of fiscal 2027.
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Earnings +14%. Price +25% over the same three years. Research kept: the price is not compressed against its own history today.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 178.5% of profit. Latest quarter 193.4% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: supported, ROCE 20.8% → 23.1% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 5 Nov 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 9 of 20 ahead
Against the S&P 500 (SPY): 13 weeks +2.2 pts · 1 year +23.7 pts · 3 years −42.58 pts
The profit jump is real in the filed numbers. Revenue rose 5.7% while acquisition-related charges and U.S. Rebate deductions collapsed, but the evidence contains no management explanation or guidance, so the 'why' is arithmetic from the filings, not management's word. Total revenue posts a year-on-year decline in either of the next two 10-Qs. The third quarter of fiscal 2027 10-Q, due around late October or November 2026, is the next checking point. That would show the Growth Portfolio ramp cannot.
33 Amcor plc55 out of 100 · tier C · basing
Consumer Discretionary · market value $20.2B
- Fundamentals32.1 of 45
- Earnings curve13.8 of 20
- Management (the why)9.0 of 35
- Management credibility0
What is driving it: Merger integration and the anticipated benefits of the Berry transaction · Main risk: Integration costs consume the merger's benefits before they arrive
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings −29%. Price −7% over the same three years.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 196.2% of profit. Latest quarter -217.8% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: supported, ROCE 5.3% → 6.9% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 27 Oct 2026
Weeks against the S&P 500 (SPY), last 20: 2 wks since beat · 9 of 20 ahead
Against the S&P 500 (SPY): 13 weeks −2.01 pts · 1 year −8.97 pts · 3 years −73.85 pts
The profit rise is real as a reported number, but it is a purchase rather than a proven improvement. Revenue and profit stepped up when Berry Global was consolidated after the merger completed on April 30, 2025. While each share actually earned less, the operating margin thinned and interest expense doubled. One measurable condition: if the December 2026 and March 2027 10-Qs show quarterly restructuring. Transaction and integration expenses still above $60m, operating margin still below the pre-merger 9.3-9.
34 StandardAero, Inc.55 out of 100 · tier B · basing · provisional
Industrials · market value $8.9B
- Fundamentals29.8 of 45
- Earnings curve11.0 of 20
- Management (the why)no data
- Management credibilityno data
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings +1423%. Price −3% over the same two years.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 95% of profit. Latest quarter 138.9% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: supported, ROCE 9.4% → 11.1% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 9 Aug 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 8 of 20 ahead
Against the S&P 500 (SPY): 13 weeks +2.22 pts · 1 year −4.03 pts · 3 years no data
The 4.2x PAT curve (TTM 294.3 vs prior-4Q 70.6, $m) is roughly HALF deleveraging math, half operations. Of the +88.3 pretax swing September 2024→March 2026. +43.2 is interest expense falling (−81.4→−38.2/qtr after the IPO paid debt from 3,611 to 2,453) and +45.0 is operating income. 98.1→143.1 on revenue +31% and operating margin 7.6%→9.0%. this read is wrong if operating margin breaks decisively above about 10% for 2+ quarters (engine-MRO supercycle pricing power exceeding the deleveraging framing). While sponsor stake sales complete without price damage, then the growth.
35 Ironwood Pharmaceuticals, Inc.55 out of 100 · tier C · alert live
Healthcare · market value $0.7B
- Fundamentals30.9 of 45
- Earnings curve13.6 of 20
- Management (the why)10.0 of 35
- Management credibility+2
What is driving it: Apraglutide. Confirmatory Phase III trial in short bowel syndrome with intestinal failure · Main risk: All revenue is one collaboration line. Total revenues equal Collaborative arrangements revenue in both filed quarters. So the whole profit base rests on the LINZESS collaboration with AbbVie and ex-US partner arrangements. A partner dispute or demand drop hits everything at once.
Promise audit: done: Initiate a confirmatory Phase III clinical trial of apraglutide in short bowel syndrome with intestinal failure. With timing, key design elements and endpoints to follow.
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings +496%. Price +57% over the same year.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 176.7% of profit. Latest quarter 113.6% · Sep 2024 to Jun 2026 · 8 quarters
- Capital returns: unknown, ROCE 94% → 98.4% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 17 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Jun 2026 · Ratios through 30 Sep 2026 · Research dated 13 Nov 2026
Weeks against the S&P 500 (SPY), last 20: beating 4 wks · 10 of 20 ahead · alert firing 1 wk
Against the S&P 500 (SPY): 13 weeks +17.87 pts · 1 year +46.09 pts · 3 years −112.68 pts
The earnings rise is real in the filed numbers. Collaboration revenue more than doubled year on year in the March 2026 quarter and rose 33% in June while overhead was roughly halved. But the supplied documents contain no management explanation of what drove it, the March profit barely converted to cash. The read that this is a durable new level is wrong if any quarter reported through March 2027 falls back under roughly $60M of revenue and $25M of net income. The wave pattern of the March 2025 and December 2025.
36 Aon plc54 out of 100 · tier B · basing · provisional
Financials · market value $71.8B
- Fundamentals31.5 of 45
- Earnings curve8.4 of 20
- Management (the why)no data
- Management credibilityno data
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Earnings +39%. Price +3% over the same three years. Research kept: recent profit is not near its best of the last twelve periods today.
- Profit source: not applicable. This is a bank, lender or insurer.
- Cash backing: not applicable. This is a bank, lender or insurer.
- Capital returns: mixed, ROE 37.7% → 43.4% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 9 Aug 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 8 of 20 ahead
Against the S&P 500 (SPY): 13 weeks −2.09 pts · 1 year −15.65 pts · 3 years −64.74 pts
Everything about the business is real. 100.3% 8Q cash conversion, 12.9% SBC, disciplined post-NFP deleveraging (18.3B to 15.7B) with buybacks stepping 250 to 600m/q. But the Marks question is what is priced in, and the answer is: full value. this B-not-A is wrong if organic revenue growth re-accelerates above 9-10% for 2 straight quarters. With operating margin expanding (NFP savings landing late) while the multiple stays about 23x. That would create genuine compounding.
37 Pinnacle Financial Partners, Inc.53 out of 100 · tier C · basing
Financials · market value $15.2B
- Fundamentals32.1 of 45
- Earnings curve11.8 of 20
- Management (the why)9.0 of 35
- Management credibility0
What is driving it: Fade of one-time merger integration cost (the only forward driver visible in the evidence. It is derived from reported numbers, not management guidance) · Main risk: Merger integration costs persist and keep eating the larger earnings base.
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Earnings −3%. Price +39% over the same three years. Research kept: the price is not compressed against its own history today.
- Profit source: not applicable. This is a bank, lender or insurer.
- Cash backing: not applicable. This is a bank, lender or insurer.
- Capital returns: mixed, ROE 9.5% → 9.6% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 9 Nov 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 9 of 20 ahead
Against the S&P 500 (SPY): 13 weeks −3.61 pts · 1 year +1.04 pts · 3 years −28.84 pts
The dollar earnings rise is real but is mostly the January 1, 2026 Synovus merger that doubled the bank's size. Not a proven operating improvement. Per-share profit for the first nine months of 2026 is below a year earlier. And the filings supplied contain no management explanation to prove any underlying mechanism. If the Form 10-Q for the quarter ending December 31, 2026 shows merger-related expense still above $50 million. And quarterly diluted EPS still below the pre-merger run-rate (nine-month 2026 EPS was $5.36 versus $5.
38 Eversource Energy51 out of 100 · tier B · basing · provisional
Utilities · market value $27.0B
- Fundamentals25.3 of 45
- Earnings curve11.6 of 20
- Management (the why)no data
- Management credibilityno data
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Earnings +14%. Price +23% over the same three years. Research kept: profit growth is below the 25% discovery rule today.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 282.3% of profit. Latest quarter 188.9% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: supported, ROCE 5.1% → 6% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 9 Aug 2026
Weeks against the S&P 500 (SPY), last 20: beating 7 wks · 11 of 20 ahead
Against the S&P 500 (SPY): 13 weeks +1.96 pts · 1 year −14.41 pts · 3 years −44.75 pts
The crash was specific damage. Offshore-wind writedowns (December 2023 -$1.29B, September 2024 -$116M), and the damage looks DONE. Wind exited in 2024 and the last 5 quarters are clean regulated earnings growing about 10% YoY on 21-24% op margins. This read is wrong (up to A/B+) if two more clean quarters pass. With FCF sustainably positive (March 2026 +$315M repeated) and equity issuance stops. That would mean the Aquarion-funded capex plan self-finances.
39 SBA Communications Corporation49 out of 100 · tier B · basing · provisional
Real Estate · market value $19.8B
- Fundamentals25.3 of 45
- Earnings curve10.0 of 20
- Management (the why)no data
- Management credibilityno data
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Earnings +104%. Price −19% over the same three years. Research kept: profit growth is below the 25% discovery rule today.
- Profit source: not applicable. This is a property company.
- Cash backing: not applicable. This is a property company.
- Capital returns: unknown. The source carries no return on equity for this company, and the other measure is never used in its place.
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Research dated 9 Aug 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 8 of 20 ahead
Against the S&P 500 (SPY): 13 weeks +5.07 pts · 1 year −16.25 pts · 3 years −86.32 pts
REIT caveat first: GAAP NI understates tower economics (D&A-heavy) and our DB has no FFO/AFFO, so every sub-score here is conservative by construction. this read is wrong if operating cash flow returns to growth for 2+ quarters (carrier capex/5G densification re-accelerating leasing revenue above the about 3%/yr escalator crawl). Then the stagnation assumption breaks and 15.
40 Franklin Resources, Inc. (renaming to Franklin Templeton, Inc. effective August 17, 2026)48 out of 100 · tier C · alert live
Financials · market value $18.4B
- Fundamentals24.8 of 45
- Earnings curve9.2 of 20
- Management (the why)14.0 of 35
- Management credibility-3
What is driving it: Private-markets (alternatives) fundraising · Main risk: GAAP operating margin collapsed to 9.2% in the June 2026 quarter on an unexplained 70% jump in general. Administrative and other expense ($312.8 million versus $183.7 million a year earlier) plus a $33.0 million intangible impairment. If these are not one-offs, the adjusted 28% margin story overstates the business.
Promise audit: management says done, not proved by the numbers: Fiscal-year private markets fundraising goal. · done: "our 19th consecutive quarter of positive flows in that asset class".
Why it qualifies: research kept. Today’s conditions do not pass · checks as of 18 Nov 2026
Earnings +15%. Price +48% over the same three years. Research kept: the price is not compressed against its own history today.
- Profit source: not applicable. This is a bank, lender or insurer.
- Cash backing: not applicable. This is a bank, lender or insurer.
- Capital returns: supported, ROE 3.8% → 10.4% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 5 Nov 2026
Weeks against the S&P 500 (SPY), last 20: beating 4 wks · 10 of 20 ahead · alert firing 1 wk
Against the S&P 500 (SPY): 13 weeks +9.21 pts · 1 year +50.2 pts · 3 years −18.93 pts
The earnings recovery is real at the top line. Revenue up 14% year on year on record $1.8 trillion of client assets and $18.4 billion of quarterly long-term net inflows. But GAAP profit fell 36% from the March quarter on an unexplained 70% jump in general expenses and a $33.0 million impairment. So the clean margin. This read is wrong if the September 2026 (the fourth quarter of fiscal 2026) results show long-term net flows back below zero. And adjusted operating margin falling below 24%. That would say the inflow inflection was a market-rally effect.
41 Tetra Tech, Inc.44 out of 100 · tier C · alert live
Industrials · market value $9.8B
- Fundamentals33.8 of 45
- Earnings curve10.4 of 20
- Management (the why)0.0 of 35
- Management credibility0
What is driving it: not stated · Main risk: Federal government revenue exposure: the 10-Q XBRL structure tags federal, state/local, commercial and international revenue as separate disclosed categories. So a material share of revenue depends on US government spending, but no dollar amounts or trends are quantifiable from the supplied clips.
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings +66%. Price +18% over the same three years.
- Profit source: unknown. Other income is missing for 28 Dec 2025, 29 Mar 2026, 28 Jun 2026, 27 Sep 2026, so the share cannot be worked out. · Sep 2025 to Sep 2026 · 4 quarters
- Cash backing: supported. Operating cash 142.6% of profit. Latest quarter 42.9% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: concern, ROCE 20.9% → 19.3% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 27 Sep 2026 · Cash through 27 Sep 2026 · Ratios through 27 Sep 2026 · Research dated 2 Sep 2026
Weeks against the S&P 500 (SPY), last 20: 1 wk since beat · 13 of 20 ahead · alert firing 3 wks
Against the S&P 500 (SPY): 13 weeks +9.18 pts · 1 year −5.03 pts · 3 years −49.75 pts
The reported quarters show a genuine margin and cash-flow recovery, but every document supplied is a filing shell with no management explanation. No forward driver and no promise history, so the qualitative 'why' behind the earnings rise is unverified rather than proven. This thin-history read becomes wrong, and the recovery thesis with it. If the fourth quarter of fiscal 2026 filings. And call transcript show revenue still declining year over year with operating margin falling back below 10% and shrinking.
42 Super Micro Computer, Inc.40 out of 100 · tier C · basing
Technology · market value $17.7B
- Fundamentals16.9 of 45
- Earnings curve12.3 of 20
- Management (the why)11.0 of 35
- Management credibility-7
What is driving it: Margin recovery from richer enterprise customer mix and DCBBS adoption · Main risk: The Board's independent review of export-control transactions could force material revisions to the preliminary fourth quarter of fiscal 2026 results and prior periods
Promise audit: missed: the third quarter of fiscal 2026 net sales of at least $12.3 billion · done: the third quarter of fiscal 2026 GAAP diluted EPS of at least $0.52
Why it qualifies: qualifies now · checks as of 18 Nov 2026
Earnings +344%. Price −7% over the same three years.
- Profit source: unknown. Other income is missing for 31 Dec 2025, 31 Mar 2026, 30 Jun 2026, 30 Sep 2026, so the share cannot be worked out. · Oct 2025 to Sep 2026 · 4 quarters
- Cash backing: concern. Operating cash -146.6% of profit. Latest quarter -34.3% · Dec 2024 to Sep 2026 · 8 quarters
- Capital returns: supported, ROCE 7.7% → 18.2% · Sep 2025 to Sep 2026 · 5 quarterly readings
Checks used prices of 13 Nov 2026 · Earnings through 30 Sep 2026 · Cash through 30 Sep 2026 · Ratios through 30 Sep 2026 · Research dated 9 Sep 2026
Weeks against the S&P 500 (SPY), last 20: 2 wks since beat · 10 of 20 ahead
Against the S&P 500 (SPY): 13 weeks −29.74 pts · 1 year −38.5 pts · 3 years −74.25 pts
The earnings jump is real as reported. A 17.5% gross-margin quarter with $1,178M net income, but it is one preliminary, unaudited quarter, explained only by management's enterprise-mix story. Sitting on a full year of negative operating cash flow funded by debt and new equity, with two missed revenue guides behind. The first quarter of fiscal 2027 report (quarter ending September 30, 2026, expected around November 2026 on the IR quarterly-results page). If net sales come in below the $14.5 billion low end of guidance, or gross margin falls back below.
71 names, one ranked list · 42 full cards, then the compact tail · names not judged yet rank last · data as of 17 Nov 2026
Which stocks passed the screen but are not graded yet?
29 names on our undervalued US list passed the screen as of 17 November 2026: profits up and the price flat or below its 3-year high. Nobody has read their books yet, so they have no tier and no score.
| Rank | Company | Industry | Screen | vs S&P 500, 13 weeks | Price alert | Status | Why it is here |
|---|---|---|---|---|---|---|---|
| 43 | Alnylam Pharmaceuticals, Inc.Healthcare · $22.1B | Healthcare · $22.1B | 3.49 | −24.99 pts | – | ungraded. Screen stats only | qualifies now. Earnings +2374%. Price −64% over the same year. |
| 44 | Albemarle CorporationMaterials · $11.0B | Materials · $11.0B | 3.2 | −28.47 pts | – | ungraded. Screen stats only | qualifies now. Earnings −85%. Price −27% over the same three years. |
| 45 | Grab HoldingsTechnology · $13.1B | Technology · $13.1B | 2.99 | −7.67 pts | – | ungraded. Screen stats only | qualifies now. Earnings +549%. Price −39% over the same year. |
| 46 | Sociedad Química y Minera de Chile S.A.Materials · $15.3B | Materials · $15.3B | 2.72 | −25.04 pts | – | ungraded. Screen stats only | qualifies now. Earnings −53%. Price +6% over the same three years. |
| 47 | Venture Global, Inc.Energy · $32.9B | Energy · $32.9B | 2.34 | −3.25 pts | – | ungraded. Screen stats only | qualifies now. Earnings +163%. Price +66% over the same year. |
| 48 | MKS Inc.Technology · $14.6B | Technology · $14.6B | 2.19 | −27.77 pts | – | ungraded. Screen stats only | qualifies now. Earnings +1824%. Price +99% over the same two years. |
| 49 | UDR, Inc.Real Estate · $12.3B | Real Estate · $12.3B | 2.18 | −1.12 pts | – | ungraded. Screen stats only | qualifies now. Earnings +55%. Price +11% over the same three years. |
| 50 | Camden Property TrustReal Estate · $10.1B | Real Estate · $10.1B | 2.16 | −7.33 pts | – | ungraded. Screen stats only | qualifies now. Earnings +415%. Price +14% over the same three years. |
| 51 | CVS Health CorporationHealthcare · $114.3B | Healthcare · $114.3B | 2.08 | −5.21 pts | – | ungraded. Screen stats only | qualifies now. Earnings +29%. Price +30% over the same three years. |
| 52 | United Microelectronics CorporationTechnology · $38.7B | Technology · $38.7B | 2.01 | −18.55 pts | – | ungraded. Screen stats only | qualifies now. Earnings +24%. Price +80% over the same three years. |
| 53 | Vishay Intertechnology, Inc.Technology · $3.6B | Technology · $3.6B | 2 | −15.51 pts | – | ungraded. Screen stats only | qualifies now. Earnings −75%. Price +13% over the same three years. |
| 54 | Occidental Petroleum CorporationEnergy · $58.7B | Energy · $58.7B | 1.96 | +3.5 pts | – | ungraded. Screen stats only | qualifies now. Earnings +64%. Price −4% over the same three years. |
| 55 | On Holding AGConsumer Discretionary · $11.2B | Consumer Discretionary · $11.2B | 1.91 | +7.21 pts | – | ungraded. Screen stats only | qualifies now. Earnings +341%. Price +22% over the same three years. |
| 56 | BP p.l.c.Energy · $117.5B | Energy · $117.5B | 1.83 | +10.28 pts | – | ungraded. Screen stats only | qualifies now. Earnings −60%. Price +28% over the same three years. |
| 57 | Ingersoll Rand Inc.Industrials · $32.7B | Industrials · $32.7B | 1.75 | +4.89 pts | – | ungraded. Screen stats only | qualifies now. Earnings +89%. Price +21% over the same three years. |
| 58 | FabrinetTechnology · $11.7B | Technology · $11.7B | 1.45 | −39.65 pts | – | ungraded. Screen stats only | qualifies now. Earnings +96%. Price +92% over the same three years. |
| 59 | Futu HoldingsFinancials · $13.4B | Financials · $13.4B | 1.43 | −6.18 pts | – | ungraded. Screen stats only | qualifies now. Earnings +154%. Price +61% over the same three years. |
| 60 | Applied Materials, Inc.Technology · $294.0B | Technology · $294.0B | 1.42 | −24.12 pts | – | ungraded. Screen stats only | qualifies now. Earnings +56%. Price +149% over the same three years. |
| 61 | Archer-Daniels-Midland CompanyConsumer Staples · $34.7B | Consumer Staples · $34.7B | 1.4 | −6.55 pts | – | ungraded. Screen stats only | qualifies now. Earnings −29%. Price −1% over the same three years. |
| 62 | Alcoa CorporationMaterials · $10.5B | Materials · $10.5B | 1.39 | −17.66 pts | – | ungraded. Screen stats only | qualifies now. Earnings +33%. Price +9% over the same year. |
| 63 | KKR & Co. Inc.Financials · $87.5B | Financials · $87.5B | 1.31 | −11.17 pts | – | ungraded. Screen stats only | qualifies now. Earnings +11%. Price +47% over the same three years. |
| 64 | Yum! Brands, Inc.Consumer Discretionary · $43.3B | Consumer Discretionary · $43.3B | 1.29 | +11.76 pts | – | ungraded. Screen stats only | qualifies now. Earnings +137%. Price +26% over the same three years. |
| 65 | LPL Financial Holdings Inc.Financials · $22.8B | Financials · $22.8B | 1.28 | −18.27 pts | – | ungraded. Screen stats only | qualifies now. Earnings +18%. Price +30% over the same three years. |
| 66 | First Solar, Inc.Technology · $18.4B | Technology · $18.4B | 1.28 | −24.27 pts | – | ungraded. Screen stats only | qualifies now. Earnings +291%. Price −1% over the same three years. |
| 67 | Nu HoldingsFinancials · $64.0B | Financials · $64.0B | 1.23 | −10.37 pts | – | ungraded. Screen stats only | qualifies now. Earnings +969%. Price +64% over the same three years. |
| 68 | Blackstone Inc.Financials · $149.4B | Financials · $149.4B | 1.18 | −13.66 pts | – | ungraded. Screen stats only | qualifies now. Earnings +89%. Price +15% over the same three years. |
| 69 | Ally Financial Inc.Financials · $11.5B | Financials · $11.5B | 1.13 | −11.87 pts | – | ungraded. Screen stats only | qualifies now. Earnings +19%. Price +39% over the same three years. |
| 70 | PepsiCo, Inc.Consumer Staples · $198.2B | Consumer Staples · $198.2B | 1.06 | +6.13 pts | – | ungraded. Screen stats only | qualifies now. Earnings +33%. Price −13% over the same three years. |
| 71 | Neurocrine Biosciences, Inc.Healthcare · $16.9B | Healthcare · $16.9B | 0.98 | +12.44 pts | – | ungraded. Screen stats only | qualifies now. Earnings +263%. Price +54% over the same three years. |
Rows marked ungraded passed the arithmetic screen, profits up, price asleep. But nobody has read their books yet: no tier, no score, ranked last by rule until someone reads them. A price alert on a judged Tier C name is ignored by rule.
The rest of the ranked list · 29 names down to the last screened · data as of 17 Nov 2026
Which US stocks on the list have the cleanest profit growth?
26 of the 42 scored names on our undervalued US list are tier A or B, 0 of them tier A, in the quality read of 16 November 2026. The tier says how clean the profit growth looks: how much profit turns into cash, who paid for the growth, and which way margins are moving.
Show the table
| Company | Industry | Score | Tier |
|---|---|---|---|
| Autodesk, Inc.Technology | Technology | 75.6 | B |
| Five Below, Inc.Consumer Discretionary | Consumer Discretionary | 75.2 | B |
| DexCom, Inc.Healthcare | Healthcare | 73.5 | B |
| Remitly Global, Inc.Technology | Technology | 68.6 | B |
| Equinix, Inc.Real Estate | Real Estate | 68.3 | B |
| Qorvo, Inc.Technology | Technology | 67.8 | B |
| MediaAlpha, Inc.Communication Services | Communication Services | 66.6 | B |
| Columbia Financial, Inc.Financials | Financials | 66 | B |
| Boston Scientific CorporationHealthcare | Healthcare | 64.2 | B |
| LiveRamp Holdings, Inc.Technology | Technology | 63.9 | B |
| Roper Technologies, Inc.Technology | Technology | 63.5 | B |
| Cognizant Technology Solutions CorporationTechnology | Technology | 62.3 | B |
| Broadridge Financial Solutions, Inc.Technology | Technology | 62 | B |
| Monster Beverage CorporationConsumer Staples | Consumer Staples | 61.8 | B |
| LATAM Airlines Group S.A.Industrials | Industrials | 61.7 | B |
| Nutanix, Inc.Technology | Technology | 61.3 | B |
| SouthState Bank CorporationFinancials | Financials | 61.1 | B |
| Fair Isaac CorporationTechnology | Technology | 61 | B |
| Dollar General CorporationConsumer Staples | Consumer Staples | 59.8 | B |
| Tradeweb Markets Inc.Financials | Financials | 59.1 | B |
| Salesforce, Inc.Technology | Technology | 58.1 | B |
| Kenvue Inc.Consumer Staples | Consumer Staples | 57.6 | B |
| StandardAero, Inc.Industrials | Industrials | 54.8 | B |
| Aon plcFinancials | Financials | 53.9 | B |
| Eversource EnergyUtilities | Utilities | 50.9 | B |
| SBA Communications CorporationReal Estate | Real Estate | 49.3 | B |
Tiers from the quality ranking, latest read 16 Nov 2026
Large cap US stocks on the deep value list
63 of the 71 names on our undervalued US list are large cap stocks, worth $10 billion or more, as of 17 November 2026. The biggest are Applied Materials, Inc., PepsiCo, Inc. and Salesforce, Inc. Each has rising earnings while its price sits below its own history.
Show the table
| Company | Market value | Score | Tier | vs S&P 500, 13 weeks |
|---|---|---|---|---|
| Applied Materials, Inc. | $294.0B | – | Not graded | −24.12 pts |
| PepsiCo, Inc. | $198.2B | – | Not graded | +6.13 pts |
| Salesforce, Inc. | $179.3B | 58.1 | B | +13.85 pts |
| Blackstone Inc. | $149.4B | – | Not graded | −13.66 pts |
| Bristol-Myers Squibb Company | $129.7B | 56.2 | C | +2.2 pts |
| BP p.l.c. | $117.5B | – | Not graded | +10.28 pts |
| CVS Health Corporation | $114.3B | – | Not graded | −5.21 pts |
| Equinix, Inc. | $104.3B | 68.3 | B | −1.55 pts |
| Monster Beverage Corporation | $90.9B | 61.8 | B | +2.06 pts |
| KKR & Co. Inc. | $87.5B | – | Not graded | −11.17 pts |
| The Cigna Group | $78.3B | 56.8 | C | +7.94 pts |
| Aon plc | $71.8B | 53.9 | B | −2.09 pts |
| Boston Scientific Corporation | $64.3B | 64.2 | B | −11.62 pts |
| Nu Holdings | $64.0B | – | Not graded | −10.37 pts |
| Occidental Petroleum Corporation | $58.7B | – | Not graded | +3.5 pts |
| Autodesk, Inc. | $55.3B | 75.6 | B | +7.9 pts |
| Waste Connections, Inc. | $48.5B | 67.1 | C | +19.48 pts |
| Roper Technologies, Inc. | $47.5B | 63.5 | B | +23.02 pts |
| Yum! Brands, Inc. | $43.3B | – | Not graded | +11.76 pts |
| Fomento Económico Mexicano, S.A.B. de C.V. (FEMSA) | $40.3B | 62.6 | C | +14.36 pts |
| United Microelectronics Corporation | $38.7B | – | Not graded | −18.55 pts |
| Kenvue Inc. | $37.1B | 57.6 | B | −0.8 pts |
| Archer-Daniels-Midland Company | $34.7B | – | Not graded | −6.55 pts |
| Venture Global, Inc. | $32.9B | – | Not graded | −3.25 pts |
| Ingersoll Rand Inc. | $32.7B | – | Not graded | +4.89 pts |
| DexCom, Inc. | $31.1B | 73.5 | B | −4.32 pts |
| Tradeweb Markets Inc. | $30.8B | 59.1 | B | +27.71 pts |
| Dollar General Corporation | $29.6B | 59.8 | B | +11.64 pts |
| Cognizant Technology Solutions Corporation | $28.2B | 62.3 | B | +10.01 pts |
| Eversource Energy | $27.0B | 50.9 | B | +1.96 pts |
| LPL Financial Holdings Inc. | $22.8B | – | Not graded | −18.27 pts |
| Alnylam Pharmaceuticals, Inc. | $22.1B | – | Not graded | −24.99 pts |
| Broadridge Financial Solutions, Inc. | $21.8B | 62 | B | +15.37 pts |
| PTC Inc. | $21.3B | 64.2 | C | +33.71 pts |
| Amcor plc | $20.2B | 54.9 | C | −2.01 pts |
| SBA Communications Corporation | $19.8B | 49.3 | B | +5.07 pts |
| TPG Inc. | $18.6B | 57.8 | C | −6.16 pts |
| Franklin Resources, Inc. (renaming to Franklin Templeton, Inc. effective August 17, 2026) | $18.4B | 48 | C | +9.21 pts |
| First Solar, Inc. | $18.4B | – | Not graded | −24.27 pts |
| Super Micro Computer, Inc. | $17.7B | 40.2 | C | −29.74 pts |
| Neurocrine Biosciences, Inc. | $16.9B | – | Not graded | +12.44 pts |
| Nutanix, Inc. | $16.3B | 61.3 | B | −6.52 pts |
| TransUnion | $15.5B | 58 | C | +3.56 pts |
| Fair Isaac Corporation | $15.4B | 61 | B | −30.84 pts |
| Sociedad Química y Minera de Chile S.A. | $15.3B | – | Not graded | −25.04 pts |
| Pinnacle Financial Partners, Inc. | $15.2B | 52.9 | C | −3.61 pts |
| MKS Inc. | $14.6B | – | Not graded | −27.77 pts |
| Five Below, Inc. | $13.6B | 75.2 | B | +3.71 pts |
| LATAM Airlines Group S.A. | $13.6B | 61.7 | B | −6.62 pts |
| Futu Holdings | $13.4B | – | Not graded | −6.18 pts |
| Grab Holdings | $13.1B | – | Not graded | −7.67 pts |
| GameStop Corp. | $13.0B | 56.3 | C | +41.36 pts |
| UDR, Inc. | $12.3B | – | Not graded | −1.12 pts |
| Fabrinet | $11.7B | – | Not graded | −39.65 pts |
| Ally Financial Inc. | $11.5B | – | Not graded | −11.87 pts |
| Bio-Techne Corporation | $11.4B | 61.7 | C | +3.38 pts |
| Wise Group plc | $11.4B | 58.9 | C | −11.38 pts |
| On Holding AG | $11.2B | – | Not graded | +7.21 pts |
| Albemarle Corporation | $11.0B | – | Not graded | −28.47 pts |
| Alcoa Corporation | $10.5B | – | Not graded | −17.66 pts |
| Qorvo, Inc. | $10.1B | 67.8 | B | +27.04 pts |
| SouthState Bank Corporation | $10.1B | 61.1 | B | −3.43 pts |
| Camden Property Trust | $10.1B | – | Not graded | −7.33 pts |
Market value as printed on the list, 17 Nov 2026 · large $10 billion+, mid $2–10 billion, small under $2 billion
Mid cap US stocks on the deep value list
5 of the 71 names on our undervalued US list are mid cap stocks, worth $2 billion to $10 billion, as of 17 November 2026. The biggest are Tetra Tech, Inc., StandardAero, Inc. and Remitly Global, Inc. Each has rising earnings while its price sits below its own history.
Show the table
| Company | Market value | Score | Tier | vs S&P 500, 13 weeks |
|---|---|---|---|---|
| Tetra Tech, Inc. | $9.8B | 44.1 | C | +9.18 pts |
| StandardAero, Inc. | $8.9B | 54.8 | B | +2.22 pts |
| Remitly Global, Inc. | $4.8B | 68.6 | B | −18.68 pts |
| Vishay Intertechnology, Inc. | $3.6B | – | Not graded | −15.51 pts |
| LiveRamp Holdings, Inc. | $2.3B | 63.9 | B | +0.5 pts |
Market value as printed on the list, 17 Nov 2026 · large $10 billion+, mid $2–10 billion, small under $2 billion
Small cap US stocks on the deep value list
2 of the 71 names on our undervalued US list are small cap stocks, worth under $2 billion, as of 17 November 2026. The biggest are MediaAlpha, Inc. and Ironwood Pharmaceuticals, Inc. Each has rising earnings while its price sits below its own history.
Show the table
| Company | Market value | Score | Tier | vs S&P 500, 13 weeks |
|---|---|---|---|---|
| MediaAlpha, Inc. | $0.8B | 66.6 | B | +16.71 pts |
| Ironwood Pharmaceuticals, Inc. | $0.7B | 54.5 | C | +17.87 pts |
Market value as printed on the list, 17 Nov 2026 · large $10 billion+, mid $2–10 billion, small under $2 billion
US bank and finance stocks on the deep value list
14 of the 71 names on our undervalued US list are banks, insurers or other finance companies, as of 17 November 2026: Columbia Financial, Inc., SouthState Bank Corporation and Tradeweb Markets Inc. For these the chart shows price to book value, not P/E, because a lender's balance sheet says more than one year's profit.
Show the table
| Company | Industry | Score | Tier |
|---|---|---|---|
| Columbia Financial, Inc.Financials | Financials | 66 | B |
| SouthState Bank CorporationFinancials | Financials | 61.1 | B |
| Tradeweb Markets Inc.Financials | Financials | 59.1 | B |
| TransUnionFinancials | Financials | 58 | C |
| TPG Inc.Financials | Financials | 57.8 | C |
| Aon plcFinancials | Financials | 53.9 | B |
| Pinnacle Financial Partners, Inc.Financials | Financials | 52.9 | C |
| Franklin Resources, Inc. (renaming to Franklin Templeton, Inc. effective August 17, 2026)Financials | Financials | 48 | C |
| Futu HoldingsFinancials | Financials | – | Not graded |
| KKR & Co. Inc.Financials | Financials | – | Not graded |
| LPL Financial Holdings Inc.Financials | Financials | – | Not graded |
| Nu HoldingsFinancials | Financials | – | Not graded |
| Blackstone Inc.Financials | Financials | – | Not graded |
| Ally Financial Inc.Financials | Financials | – | Not graded |
Industry as printed on the list, 17 Nov 2026
Undervalued US stocks under $20 a share
9 names on our undervalued US list closed the week to 17 November 2026 under $20 a share, among them MediaAlpha, Inc., Columbia Financial, Inc., Wise Group plc and Kenvue Inc. A low share price on its own says nothing about the business. The table gives each one's price, score and tier.
Show the table
| Company | Price now | Score | Tier |
|---|---|---|---|
| MediaAlpha, Inc. | $14.54 | 66.6 | B |
| Columbia Financial, Inc. | $10.94 | 66 | B |
| Wise Group plc | $11.23 | 58.9 | C |
| Kenvue Inc. | $19.31 | 57.6 | B |
| Ironwood Pharmaceuticals, Inc. | $4.87 | 54.5 | C |
| Grab Holdings | $3.24 | – | Not graded |
| Venture Global, Inc. | $13.14 | – | Not graded |
| United Microelectronics Corporation | $14.14 | – | Not graded |
| Nu Holdings | $13.22 | – | Not graded |
Weekly close of 17 Nov 2026
How do you identify an undervalued stock?
This list does not use a fair-value model. It looks for two things in each company's own numbers: earnings rising, and a share price below the stock's own history. 71 US companies are on it on 17 November 2026, and 42 of them are scored out of 100.
United States · against the S&P 500 (SPY) · quality ranking updated weekly for names whose price is moving · latest read 16 Nov 2026 · prices and alerts refreshed weekly · data as of 17 Nov 2026
Which stocks have left the list after their price doubled?
None so far, as of 17 November 2026. A name leaves our undervalued US list once a weekly close is double its price on the day it entered, because a price that has doubled is no longer deep value. Each name that leaves is listed here with its gain.
Graduation rule: a weekly close 100% or more above the price on the day the name entered, checked every week
How do I read this page?
Our undervalued US list, as of 17 November 2026, holds companies whose profits are rising while the price sleeps. A quality ranking out of 100 sets the order: 45 points from fundamentals, 20 from the earnings curve and 35 from a management promise audit.
- Profits rising while the price sleeps. Two layers: a quality ranking out of 100 sets the order, re-read for any name whose price starts moving. It gives 45 points from fundamentals, 20 from the earnings curve, 35 from a management promise-audit. A weekly data refresh updates prices, the earnings picture and price alerts. The rank never moves on price alone.
- TIER (A/B/C) is the quality of the earnings curve. It is judged from cash conversion, who funded the growth, and margin direction. TAGS are the momentum state from the weekly alert engine. The two never mix.
- Charts. The top 5 cards show the weekly price with its 200-day average over the last 52 weeks. The top 3 also show the earnings per share of the last 12 months at each quarter. The P/E, or price to book for finance companies, sits under it. Every chart value is also printed in a table under the chart. The checks carry their reasons on the top 10 cards. The dot strip shows the last 20 weeks, and green = beat the index that week. The small dots beside it are the price-alert trigger. "Alert firing N wks" counts how long it has stayed true.
- Rank never moves on price. We read a company's books again in the week its price starts moving, and the score it earns then stays with it. The most recent reading was on 16 November 2026. A price alert is a reason to look at a name, never a reason to move it up or down the list. The weekly pass only refreshes charts, tags and alerts.
- One list, one scale: every name we have graded is ranked by its score out of 100. This is so whether or not we have read its management record yet. A missing reading is not a demerit. And a name marked "provisional" borrows the typical reading of the names we have read for that last part of its score. Only "ungraded" names rank last, because they have no score at all. They are through the arithmetic screen, books not opened.
- Names leave. Once a share price is double its price on entry, it is no longer deep value and it drops off.
- Weeks strip on each card: ● is a week the share beat the index, ○ a week it did not, oldest first. "Beating N wks" counts the weeks in a row ahead of the index.
- What the US data cannot show: we have no record of what the big funds own. The cash-flow figures in a US quarterly filing count from the start of the financial year rather than from that quarter alone. And the earnings feed is missing some fourth quarters.
United States · against the S&P 500 (SPY) · quality ranking updated weekly for names whose price is moving · latest read 16 Nov 2026 · prices and alerts refreshed weekly · data as of 17 Nov 2026
Questions about this list
Which US stocks are at the top of the deep value list right now?
These are the three highest-ranked US names as of 17 November 2026. Autodesk, Inc. scores 76 out of 100. Five Below, Inc. scores 75 out of 100. DexCom, Inc. scores 74 out of 100. On this list each one trades at a multiple below its own multi-year median while reporting rising earnings. That is a comparison with the stock's own past, not a forecast. We’re not SEBI-registered.
How is this list ranked and how often does it change?
The order is set by a quality ranking out of 100 that is re-read the week a name's price starts moving. It gives 45 points from published fundamentals (profit growth, return on capital, cash conversion). It gives 20 from the shape of the earnings curve over time. And 35 from a management promise-audit: whether promised goals were actually delivered. Every graded name sits on that one scale. A name whose management record has not been read yet is marked provisional. It borrows the typical reading of the names that have been read, so waiting for a reading never pushes a company up or down. A name keeps the score it earned until it is read again. It drops off the list altogether once its price has doubled from where it entered. Prices, the earnings picture and price-alert status update every week. But a price move alone never changes a stock's position.
Does being on this list mean a stock will rise?
No. The strongest read this page gives is "worth studying deeper", not a recommendation. A stock can stay low for years while earnings continue to improve, or re-rate before the fundamentals do. Use the rankings as a research queue, starting with the fundamentals and management track record, not the multiple alone. We’re not SEBI-registered.
More lists
All 41 lists across India and US